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Wilsons disease is an autosomal recessive disorder ofcopper metabolism which
results from mutations in the gene encoding for Wilson disease protein (WDP). The
cytosolic N-terminus ofWDP comprises six metal binding domains each containing a
conserved metal binding motif, GMXCXXC. The contribution ofthese metal binding
domains to copper homeostasis is poorly understood. We have cloned, expressed and
purified residues 485 to 633 corresponding to N-terminal metal-binding domains 5 and 6
ofWDP (WD5-6). Two ofthe 3 disease causing mutations in the N-terminal metal
binding domains ofWDP occur one in each ofthese domains and the two domains have
been shown to be essential for copper induced response, catalytic phosphorylation and
other functions ofWDP.
We found that WD5-6 binds 2 equivalents ofcopper, has a pl of4.97 and behaves
as a monomer in solution. We also showed by NMR titration that WD5-6 accepts copper
from the fourth metal binding domain ofWDP, Cu(l)WD4, and not from Cu(l)Atoxl , the
copper chaperone that delivers copper to WDP. Solution NMR structure ofapo-WD5-6
was elucidated and found to consist of2 ferrodoxin-like folds that behaves as a unit in
solution.
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CHAPTER I
INTRODUCTION
Copper homeostasis
Copper is an essential trace element that is a cofactor in several key enzymes

.,,.

(Linder, 1991). Some of tlie enzymes whose activity depend on copper are cytochrome c
oxidase in the electron transport chain, superoxide dismutase for free radical
detoxification, tyrosinase for melanin production, dopamine 8-hydroxylase for production
of neurotransmitters and lysil oxidase for cross-linking collagen (Danks, 1980, 1995).
Interaction of Cu with hydrogen peroxide rather than redox coupled partners can yield
deleterious hydroxyl radical, which may lead to oxidative damage

(DiGuiseppi &

Fridovich, 1984). · Therefore Cu is both essential as a redox catalyst in several oxidases
and potentially deleterious due to its ability to cause DNA damage, inactivation of certain
enzymes and lipid peroxidation when it accumulates in the tissues (Carmichael et al.,
1995; Gu et al., 2000; Nair et al., 1998).
Cu homeostasis must therefore be tightly controlled such that enough Cu is
delivered to Cu-requiring enzymes while preventing excess build up in the cytoplasm.
Proteins involved in the uptake, distribution, secretion and efflux of Cu include high
affinity permeases for copper uptake, Cu chaperones for distribution to target Cu
requmng proteins, and Cu transporting P-type ATPases which transport Cu in the
secretory pathway and export Cu when in excess (Huffman & O'Halloran, 2001;
Prohaska & Gybina, 2004). The liver plays a crucial role in Cu balance in the body. Most
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of the Cu absorbed from the intestine is received in the liver and biliary excretion of Cu is
also closely connected to the liver (Tao & Gitlin, 2003).

Intracellular copper pathways

Cu is uptaken into the cell by a plasma membrane protein, Ctr l , which acts as a
high affinity permease (Lee et al., 2001). Cu(DiDonato et al.) is first reduced to
Cu(Anastassopoulou et al.) during its uptake across the plasma membrane by mechanism
that is still unknown (Lee et al., 2002; Puig et al., 2002). Extremely low free Cu ions
exist in the cytoplasm (Rae et al., 1999). Once in the cell, Cu is bound to Cu chaperones
which deliver it to the target proteins through an efficient metallochaperone network
(O'Halloran & Culotta, 2000) (Figure 1). In humans, Atoxl deliver Cu to the membrane
associated Cu transporting ATPases; Wilson's disease protein (WDP) and Menkes
disease protein (MNK), CCS delivers Cu to Cu/Zn superoxide dismutase (SOD) while
Coxl 7 supplies cytochrome c oxidase with Cu. Other putative Cu handling proteins
include Murrl (Tao et al., 2003), metallothionine (MT-1 and MT-2) and amyloid
precursor protein (APP) (V. C. Culotta et al., 1999; Prohaska & Gybina, 2004). WDP and
MNK then use energy derived from ATP hydrolysis to translocate Cu into the secretory
pathway and to export the excess into the bile (Hung et al., 1997).
SOD is responsible for free radical detoxification. It catalyses the dismutation
reaction of the toxic superoxide radical to molecular oxygen and hydrogen peroxide as
follows;
Cu[II]- SOD + 0 2 ·-

----=a...

-...:--

Cu[/]- SOD+ 02

3

SOD thus forms a crucial part of the cellular antioxidant defense mechanism (Lavelle et
al., 19_73; Paschen & Weser, 1973). Cytochrome c oxidase is a membrane protein which

catalyzes reduction of the dioxygen molecule to water in the last step of electron transfer
chain in cell as shown below.
4Fe 2+ +4H + +02

�

4Fe 3+ +2H2 O (Tsukihara et al., 1995)

Cerulop lasmi n

E) - ►

G

CTR1

Figure 1. Intracellular pathways of Cu. Ctrl permease imports Cu into the cell after
which it is bound to various Cu chaperones; Atox l, CCS and Cox l 7. These
metallochaperones in tum deliver Cu to target membrane proteins ATP7B (WDP) at
TGN (trans-Golgi network) for translocation into different cell compartments, Cu/Zn
SOD and Cyt c oxidase.
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Wilson's disease

Wilson's disease is an autosomal recessive disorder of Cu metabolism. Patients
accumulate Cu in the liver, kidney and to some extent, brain (Wilson, 1912). Wilson's
disease affects 1/30,000 births worldwide (Golian & Golian, 1998). Common symptoms
observed in patients include liver cirrhosis, degeneration of nervous system and renal
dysfunction (Brewer & Yuzbasiyan-Gurkan, 1992). Most Wilson's disease patients have
reduced Cu incorporation into ceruloplasmin, which is a multicopper oxidase in serum,
(Scheinberg & Gitlin, 1952) and impaired biliary excretion (Frommer, 1974; Sternlieb,
1984).
Treatments that are used to manage Wilson's disease include chelating agents
such as penicillamine and high doses of zinc salts (Golian & Golian, 1998). High doses
of zinc salt prevent absorption of Cu. Cu may also play a role in Alzheimer's disease
(Huang et al., 1999) and prion diseases (Viles et al., 1999)

Menkes disease

The importance of Cu homeostasis is underscored by Menkes and Wilson's
disease (V. C. Culotta, Gitlin,· JD, 2001; Danks, 1995), two related inherited diseases
which show both the essential and toxic nature of Cu. Menkes disease is characterized by
Cu deficiency due to defective transport across the placenta and intestinal uptake of Cu
(Schaefer & Gitlin, 1999). Cu transport across the blood-brain barrier is also impaired
leading to severe Cu deficiency in the central nervous system (Danks, 1995). Menkes

5
disease is caused by mutations in the gene coding for Menkes disease protein, MNK. The
main symptoms of Menkes disease are neurological defects and eventual death in
childhood (Schaefer & Gitlin, 1999). Prevalence rate reported for Menkes disease is
1: 100,000 births (Danks, 1980). Intravenous administration of copper-histidine complex
is the preferred treatment to Menkes disease (Christodoulou et al., 1998).

,,.

Wilson's disease protein (WDP) and Menkes disease protein (MNK)

WDP and MNK are part of a large family of P-type ATPases found in most of
life forms. They translocate Cu ions across vesicle membranes. WDP is localized in the
trans-Golgi network (TON) of hepatocytes where it transports Cu to key metalloenzymes
such as ceruloplasmin in the secretory pathway (Hung et al., 1997). Analysis of cDNA of
the two proteins reveals that they share 57% sequence homology (Cox, 1999). In bacteria,
E. hirae, two ATPases CopA and CopB serve in uptake and efflux of Cu respectively.

CopA shows extensive sequence identity to the MNK. Mutagenesis of CopB leads to Cu
sensitive cells while disruption of CopA makes the cells Cu-dependent (Odermatt et al.,
1993). Ccc2 is the WDP homologue in yeast and it performs a similar function in yeast

(Yuanetal., 1995).

Structures of WDP and MNK
Both WDP and MNK have eight putative transmembrane domains of which the
sixth bears a CPC (cystein-proline-cystein) motif which is thought to bind metal ions
(Lutsenko et al., 2002). In addition, there are six soluble N-terminal metal binding
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domains each containing a conserved CXXC metal binding motif (Solioz & Vulpe,
l 996)(Figure 2). The gene that encodes WDP is localized on chromosome 13 at loci
q l4.3. (Frydman et al., 1985) WDP is 1411 amino acid residues long and is predicted to
have a MW of 159 kD (Bull & Cox, 1994).
The yeast homologue of WDP, Ccc2, contains two N-terminal metal binding
domains each bearing the conserved CXXC metal binding motif (Yuan et al., 1995).
Human copper chaperone, Atoxl , and its homologues found in both eukaryotes and
prokaryotes contain a single CXXC motif (Elam et al., 2002). The gene that encodes
MNK is localized to q13 loci of the X-chromosome (Tonnesen et al., 1992). MNK is
expressed in all tissues other than the liver and is composed of 1500 amino acid residues
(Vulpe et al., 1993).

''
,,·

Com.ain 5

Dom;Jln G

Dom.11n 4

_1

Figure 2. WDP model showing the six N-terminal metal binding domains and
transmembrane domain by Huffman D.L.
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Functions of WDP and MNK
WDP and MNK proteins function to transport Cu to enzymes synthesized within
secretory compartments and to export excess Cu into the bile. These dual functions
contribute to copper homeostasis. In order to carry out these functions, WDP and MNK
are themselves regulated by several factors like Atoxl and Cu concentration.

Regulation of WDP and MNK
Even though Cu uptake through Ctrl is a critical step in the supply of Cu to the
liver cells, the continuous accumulation of Cu in hepatocytes of WD patients despite
massive increases in the total hepatic Cu content suggest that Cu homeostasis is not
regulat�d at the uptake step (Gitlin, 2003). Atoxl mediated Cu transfer activates WDP
(Walker et al., 2002). It has been shown that Atoxl can carry Cu to N- terminal WDP (N
WDP) as well as remove Cu from it. This points to the fact that both metallated and apo
forms of Atoxl may contribute to the regulation of WDP activity (Walker et al., 2002).
Cu binding to N-WDP has been shown to induce a metal-specific conformational
change in this protein (DiDonato et al., 2000). This conformational change is tied to
cytosolic Cu concentration so it's likely for Cu bound state of WDP to regulate the
activity of the transporter (Fatemi & Sarkar, 2002). Circular dichroism (CD)
spectroscopy data showed that Cu binding actually induces conformational changes in
WDP (DiDonato et al., 2000). The Cu occupancy of WDP affects its intracellular
localization, post-translational modification and activity (Vanderwerf et al., 2001).
Atoxl may play key role in these events by controlling the amount of Cu bound to the
transporter and hence contribute substantially to the regulation of the intracellular
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localization or post-translational modification of WDP while keeping it active at a wide
range of Cu concentrations.
CD and X-ray absorption spectroscopy (XAS) have been used to characterize Zn
binding to the N-WDP. It has been revealed that Zn is able to bind to this domain with
stochiometry of 6: 1 (Gross et al., 2000). Zn binding induces a conformational change in
the N-WDP too but the changes are completely different from those observed with Cu
binding and leads to overall loss of secondary structure in the domain. XAS spectra show
that Zn is ligated by nitrogen atoms and therefore has low affinity for the heavy metal
associated binding motifs where Cu binds. This difference in binding may serve as the
basis for the metal-ion mediated regulation of the ATPase in vivo (Gross et al., 2000).
A study using the N-terminal model of WDP homologue in rat, rCBD, showed
that rCBD undergoes metal-induced secondary and tertiary structural changes similar to
those observed for WDP (Tsay et al., 2004). Analysis of far UV CD spectra of rCBD
suggests that Cu(I) binding to sensor N-MBD induces a conformational change (Tsay et
al., 2004). Incubation of the metallated Atoxl with full length N-terminal metal binding
domains of WDP lead to transfer of 6 Cu atoms per protein molecule. Incubation of Cu
Atoxl with full length WDP resulted in stimulation of WDP catalytic activity while
incubation of Cu-WDP with apo-Atoxl lead to removal of Cu and down-regulation of the
protein's catalytic activity (Walker et al., 2002).

Catalytic phosphorylation of WDP and MNK
In addition to its role as a cofactor to several enzymes, Cu has been shown to
regulate crucial post-translational events such as protein phosphorylation. Cu modulates
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phosphorylation of its key transporter in humans, WDP (Vanderwerf et al., 2001 ). Cu
induced phosphorylation was found to be fast and specific and it correlates with the
intracellular location of WDP. Cu induced phosphorylation seemed to require the
presence of the N-terrninal domain of this protein. This discovery may be significant in
understanding how Cu transport is regulated in mammalian cells (Vanderwerf et al.,
-,

2001). It was proposed that WDP phosphorylation could be among the molecular
mechanisms by which Cu regulates its own metabolism cells (Vanderwerf et al., 2001).
MNK is transiently phosphorylated by ATP in a Cu-specific and dependent
manner and appears to undergo conformation changes in accordance with the classical Ptype ATPase model (Voskoboinik et al., 2001). The data obtained from this study also
suggest that the catalytic cycle of the MNK protein begins with the binding of Cu to the
high affinity binding sites in the transmembrane channel, followed by ATP binding and
transient phosphorylation.

Interaction between Atox1 and WDP
Human Cu chaperone, Atox1, plays a key role in Cu distribution to the secretory
pathway of the cell. Some insight on the interaction between WDP and atoxl has been
got from studies done on yeast. Atxl which is the Atoxl ortholog in yeast has been
shown to transfer Cu to Ccc2, which transports Cu into the late Golgi compartment
(Pufahl et al., 1997). This point is supported by evidence from an experiment involving a
deletion of the Atox1 gene in mice leading to intracellular Cu accumulation and
decreased activity of secreted Cu dependent enzymes such as tyrosinase (Hamza et al.,
2001).
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Several studies have shown evidence for physical interaction between Atox 1 and
some of the N-terminal metal binding domains of WDP and MNK (Hamza et al., 1999;
Larin et al., 1999; Lockhart & Mercer, 2000; van Dongen et al., 2004). A study utilizing
a glutathione S-transferase-Atoxl fusion protein showed direct protein-protein interaction
between Atox1 and WD 1-4 which is dependent on the presence of copper ligands,
CXXC, in the N-terminus ofAtox1 (Hamza et al., 1999). This finding was supported by a
coimmunoprecipitation experiment which revealed that Atoxl interacts with both WDP
and MNK in the cells in a Cu dependent manner (Hamza et al., 1999). A similar study
carried out to test disease-associated mutations in the N-WDP showed a decrease in
Atoxl interaction with mutated WDP proteins (Hamza et al., 1999). Impaired Cu delivery
by Atoxl is thought to constitute a molecular basis of Wilson's disease in patients
harboring these mutations (Hamza et al., 1999).
A systemic yeast two-hybrid screening of interaction between Cu binding
domains showed that Atoxl interacts with MBDs 2 and 4 of WDP. Other interactions
detected are between Atxl with Ccc2, MBDs 2 and 4 ofWDP. WDP MBD 4 showed the
strongest interaction with Atoxl and Atxl ofall the 6 single metal binding domains (van
Dongen et al., 2004). All the interactions between Atoxl and single copper binding
domains were found to be weaker than interaction between Atox1 with the fragment
containing the first four copper binding domains of WDP (van Dongen et al., 2004).
Interaction between Atox 1 and the first four copper binding domains had been shown to
be strong (Larin et al., 1999). It had been shown earlier that Atox1 interacts with MBDs
1, 2 and 3 ofWDP (Larin et al., 1999). No interaction was shown between any two single

11
copper binding domains of WDP and Ccc2. Metal binding domains 5 and 6 showed no
interaction with Atox I (van Dongen et al., 2004).
The transfer of one Cu metal ion from Atoxl to N-WDP results in selective
shielding of cysteine in MBD2 against labeling with a cysteine-directed probe, a fact that
is not observed when free Cu is added to MBD2 (Walker et al., 2004). It was also
realized that site-directed mutagenesis of MBD2 knocks out the stimulation of the
catalytic activity of WDP by the Cu-Atoxl complex but not by free Cu. Based on these
results, the authors suggested that Atoxl specifically delivers Cu to MBD2 of WDP
(Walker et al., 2004). The authors also proposed that the preference of Atoxl for MBD2
may not be due to higher Cu binding affinity of MBD2 compared to the other five MBDs
nor appropriate exposure of the metal coordinating residues but is likely due to specific
protein-protein interactions. This specific interaction is enabled by the complementation
of the negatively charged patch at the surface of MBD2 and positively charged patch on
Atoxl.
The authors observed that Cu bound to MBD2 didn't migrate to the other MBD
and this fails to support the idea that MBD2 may be the entrance point of Cu transfered
from Atox 1 into N-WDP, but rather, suggests that Cu binding to MBD2 is likely to work
as a switch allowing subsequent loading of other sites. MBD2 was found to retain Cu
much better than Atoxl by competition experiments using a Cu chelator. This may
promote metal transfer process from Atoxl to MBD2.
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Electrostatic surface complementation between P-type ATPases and copper chaperones
The solution NMR structure of Ccc2a, the first MBD domain of WDP homologue
in yeast, revealed a negatively charged patch near the Cu binding region (Banci et al.,
200 l ). The negative patch is formed by the presence of several glutamate and aspartate
residues including two aspartates and one glutamate that are largely conserved among
metal-transporting ATPases (Banci et al., 2001). A very similar negative patch is evident
in generated structure of fourth MBD of human MNK (Gitschier et al., 1998). A
complimentary array of lysine and arginine residues in the vicinity of the metal binding
site of Atxl fonns a positively charged patch (Rosenzweig et al., 1999)(Figure 3). These
complimentary surface charges may play a crucial part in the interaction and Cu
exchange between Atxl and the target MBD.

Copper coordination by WDP and Atoxl
X-ray absorption spectroscopy (XAS) studies on MBD2 of WDP found that it
coordinates Cu in a similar manner as Atox1. EXAFS experiments showed that MBD2
+

and Atox1 bind Cu with a linear coordination and the distance between sulfurs in the
cysteine residues to the Cu is 2.16A (Ralle et al., 2003). This observation hints at the fact
that the near non-coordinating ligands in the MBS2 and Atoxl are responsible for the
difference in their Cu binding properties (Walker et al., 2004).
Electron paramagnetic resonance (EPR) analysis of Cu bound MBD1 of MNK
showed no signal. This confinned that Cu bound to MBDl is in the +1 oxidation state
and not +2 (Jensen et al., 1999). Cu (I) binds to MBD1 of MNK in a 1: 1 stochiometry
with an apparent Kd of 46 µM., according to an equilibrium dialysis study carried out by
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the Jensen's group. Oxidized MBD l was, however, found not to bind Cu (Jensen et al.,
1999). It was also found that N-WDP and N-MNK readily bind Cu both in vitro and in
vivo with a stochiometry of 6.5-7.3 per N-WDP or N-MNK (DiDonato et al., 1997)

leading to a suggestion that each of the six MBDs is involved in Cu coordination.
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Figure 3. Electrostatic potential surface of the Cu(l)-Ccc2a, (A), Ag(l)-MBD4 (MNK),
(B) and Cu(I)-Atxl , (C) (Banci et al., 2001).
Metal ion specificity
Several studies have shown that despite a high level of sequence similarity, P l
type ATPases are very discriminative in transporting metal ions. For example an E. coli
P-type ATPase, ZntA, is specific for ions Pb(II), Zn(II), Cd(II), and Hg(II), while WDP,
MNK and CopA (from E.coli) and homologues transport Cu(I) and possibly Ag(I). A
study using a chimeric protein of ZntA with the N-terminal domain interchanged with
either the whole N-WDP or only the sixth MBD of WDP replacing the N-terminal of
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ZntA found that both chimeras conferred resistance to lead, zinc, and cadmium salts but
not Cu salts. The purified chimeras displayed ATPase activity with zinc, lead, mercury
and cadmium which are all ZntA substrates, but no activities for Cu or silver, which are
WDP substrates. The chimeras were also less active than wild type ZntA.
The N-terminal domain cannot alter metal specificity dictated by the
transmembrane segment and it interacts with the rest of the transporter in a metal ionspecific manner (Mitra & Sharma, 2001 ). A related study found that Zn actually binds
WDP but is ligated to nitrogen atoms and not sulfur as for Cu. This binding also induces
a conformational change different from the one observed upon Cu binding. This may
suggest a possible structure-based mechanism for the discrimination of different metal
ions in vivo (DiDonato et al., 2002).
WDP and MNK were found to be discriminative in the metal ion that they bind
and transport across the membrane. A study using immobilized metal ion
chromatography revealed that the fusion protein of N-WDP is able to bind transition
metals with different affinities as follows: Cu(Il)>>Zn(Il)>Ni(l)>Co(II). Zn (II) only
binds in the pH range of 6.5 to 9.0. N-WDP however showed no affinity for Ca(II) and
Mg(II) compared to Cu. It also did not bind Fe (11) and Fe (III) (DiDonato et al., 1997).

Copper-induced relocalization of WDP and MNK
Under normal copper concentration, WDP and MNK are localized in the transGolgi network(TGN) where they help incorporate Cu(I) ions into copper-dependent
enzymes, but when copper levels are elevated, most of the MNK traffic from the TGN to
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the plasma membrane, while WDP relocates primarily to the intracellular vesicular
compartments (Pena et al., 1999; Strausak et al., 1999).

N-terminal metal binding domains of WDP and MNK

WDP and MNK each have six metal binding domains (MBD) which are about 70
amino acids long and share 20-60% homology at their N-terminus. This low similarity in
sequence suggest that they may be functionally non-equivalent, possibly with respect to
interaction with the copper chaperone Atox1 (Hamza et al., 2001; Hamza et al., 1999).
The solution NMR structure of the fourth MBD of MNK shows that it has a compact
structure with pappap 'ferredoxin-like' fold (Gitschier et al., 1998). This structure, which
was determined by heteronuclear NMR method, however, differs from the crystal
structure of the same protein in which two Atoxl molecules coordinate a single metal ion
with retention of the pappap fold (Wernimont et al., 2000). The solution NMR structure
of apo- and Cu(I)-Ccc2a from yeast also showed a ferrodixin-like fold (Figure 4).
A Cu binding site, CXXC, is housed in the highly conserved motif GMTCXXC
which forms a loop within each of the MBDs. Conserved residues in all MBDs are
clustered close to this loop thereby forming a suitable environment necessary for
accepting Cu from intracellular Cu donors such as Atoxl . Cu-induced conformational
analysis showed that both secondary and tertiary structural changes take place upon Cu
binding. These changes are thought to play both regulatory and functional roles in vivo
(DiDonato et al., 2000).
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Figure 4. Backbone atoms for the solution structure of apo-Ccc2a (A) and Cu(l)-Ccc2a.
(B) A tube with variable radius proportional to the backbone residue mean standard
deviation value of each residue (Banci et al., 2001 ).
Non-eguivalency ofMBDs
The function of the six MBDs of WDP and MNK in Cu balance is not well
understood. Several genetic and biochemical studies suggest that MBDs perform
different functions. Yeast complementation assays indicate that MBD 6 alone is sufficient
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for loading Cu into Fet3, the yeast homologue of cerulloplasmin. (Forbes et al., I 999;
Iida et al., 1998). The second and third MBDs could not substitute for the sixth MBD in
loading Cu to Fet3. Put together these findings suggest distinct functions for individual
domains. Moreover a study done using WDP variants with mutations or truncation in the
N-WDP found that Cu stimulates catalytic activity cooI?eratively and that this requires the
presence ofMBDs 5 and 6 (Huster & Lutsenko, 2003). Mutations in MBD6 or MBDsl-5
lead to non-cooperative activity of WDP by Cu whereas deletion of MBD 1-4 doesn't
affect cooperative catalytic phosphorylation activity of WDP (Huster & Lutsenko, 2003).
MBDs 5 and 6 together regulate the affinity ofintra-membrane binding sites for Cu.
These data imply that MBDs 5 and 6 may be more functionally important than
MBDs 1-4, which are thought to control access of Cu to these later domains (Huster &
Lutsenko, 2003). This findings are in contrast to those of yeast complementation studies
on MNK which show that MBDs 1-4 are important for Cu transport (Payne & Gitlin,
1998). MBDs 4-6 ofMNK were found to be essential for relocalization ofMNK from the
trans-Golgi network to the plasma membrane in response to Cu elevation in the cell
(Voskoboinik et al., 1999).

Association constant and stoichiometry of Cu (I) binding
A study using isothermal titration calorimetry (Frydman et al.) to measure the
association constant Ka and stoichiometry (n) values for Cu(I) binding to WDP MBDs
and Atoxl found that the association constants range from 105 M-1 to 106 M-1 and are
similar for the chaperone and target domains (Wernimont et al., 2004). These results
therefore imply that Cu handling by Atoxl and Cu exchange between the chaperone and
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WDP are under kinetic and not thermodynamic control. The same study also showed that
Cu binding properties of each domain are affected by the presence of the other domains.
The MBDs have similar affinities so their functional differences may be conferred by the
protein fold and electrostatic surface properties.

.....:,.

Mutations in the WDP gene
More than 100 mutations have been found in the gene encoding WD (Krawczak
& Cooper, 1997). Three well characterized disease causing mutations have been detected
in N-WDP. These mutations have been identified as G85V in MBD l , L492S in MBD5
and O591D in MBD6 (Loudianos et al., 1996). All three mutations are in the highly
conserved regions. This implies an essential structural role of these MBDs. Molecular
modeling of these missense mutations using the NMR solution structure of the fourth
copper-binding domain of the MNK indicates the potential of these mutations to disrupt
the tertiary structure of this region (Loudianos et al., 1996).
The mutant proteins were found to be express at the same level as the wild type
protein in cells by immunoblot analysis (Hamza et al., 1999). The mutants were found to
be localized at the trans-Golgi network, the same as in the wild type, by
immunofluorescent microscopy. Each of the 3 mutations, however, led to decreased
interaction with Atox1 (Hamza et al., 1999). Another mutant, P985A, showed no
decrease in Atox 1 binding under the same conditions. The discovery that WDP mutations
disrupt Atox1 binding is significant and may be very helpful in the search for a cure for
WD. These data imply that binding of Atoxl to N-WDP is important in Cu homeostasis
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(Hamza et al., 1999). Atox I is therefore a possible target for therapeutic approaches
aimed at treating WD

WD5-6
These are the two N-WDP MBDs nearest to the membrane. They consist of 149
amino acid residues (Figure 5) with a predicted molecular weight of 16,049 Da. There are
two metal binding motifs, CXXC, one in each of the domains. The unique short linker
between these two domains is also present in orthologs bearing two or more MBDs in
other species (Amesano et al., 2002). The longest linker of about 57 residues in WDP
occurs between MBD 4 and MBD5 (Amesano et al., 2002) which suggests that MBD5
and MBD6 may operate as a unit and therefore present an excellent module for studying
the influence of one domain on another. Two of the three missense disease causing
mutations in the N-WDP occur in MBD5 and MBD6 (Loudianos et al., 1996). These
mutations have been shown to abrogate the interaction between N-WDP domains and the
Cu chaperone, Atoxl , with N-WDP (Hamza et al., 1999). Presence of MBDs 5 and 6 and
not MBDs 1-4 was shown to be essential for the cooperative catalytic phosphorylation
activity of WDP (Huster & Lutsenko, 2003). These two domains have also been found to
be essential for the Cu7induced trafficking of WDP from the trans-Golgi network region
to the plasma membrane (Voskoboinik et al., 1999).
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APQKC F QIKGMTCA Sl'YSNIERNL QKEAGYLSVL VALMAGKAEI K YDPEVIQPL

541 EIAQFIQDLG FEAAYMEDYA GSDGNIELTl TGMTCASCVH NIESKL TRTN ITYASVALA
601 TSKALYKFDP EIIGPRDIIK l�EEIGFHAS LAQ

Figure 5. Amino acid sequence for WDS-6 protein. Residues highlighted in green are the
mutations in MBD5 (L492S) and in MBD6 (G591D). Cysteins that participate in copper
coordination are highlighted in red and the residues highlighted in blue are the highly
conserved methionine residues which are part of the metal binding motif.
Significance of this study

Wilson's disease affects Cu balance in the body leading to severe liver cirrhosis,
neurodegenerative disorders and other serious symptoms (Wilson, 1912). The discovery
of proteins that uptake, distribute, store and efflux excess Cu opened a new frontier in the
search for a cure for this disease (O'Halloran & Culotta, 2000). Several treatments for
WD have been developed but more specific information on the molecular
parthenogenesis of this disease is still lacking. The N-terrninal metal binding domains of
WDP and MNK play an important role in receiving Cu from the chaperones (Forbes et
al., 1999) and initiating catalytic activity through interaction with the chaperones
(Vanderwerf et al., 2001).
Two of the three disease causing mutations in the N-WDP occur in WDS-6, one
in each of the domains (Loudianos et al., 1996). These mutations are thought to disrupt
interaction of the full length N-terrninal metal binding domains with Atoxl, which
delivers Cu to WDP. Therefore full characterization of these two domains may greatly
enhance our understanding of regulation of WDP functions and how disruption of its
function affects Cu homeostasis.
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Several structural studies of single metal binding domains of P-type ATPases
have been reported. Solution NMR structure of Cu(I) bound and apo forms of the second
(Banci et al., 2004), the fourtlf(Gitschier et al., 1998) MBDs ofthe MNK, Cu(I) and apo
forms of yeast copper transporter domain Ccc2a, (Banci et al., 2001) have also been
elucidated. No solution NMR structure of any of the si_x metal binding domains of WDP
has been reported yet. WDS-6 is a unique multi-domain construct because the two
domains seem to be more functionally important and bear a short linker between them,
preceded by a long linker between domains 4 and 5. This is the first structural study of a
multi-domain construct ofN-WDP domains reported to date.
It's been shown that WD5 and WD6 don't interact with Atoxl (van Dongen et al.,
2004) and therefore may be receiving Cu from the other domains that interact with the
Atoxl. Two domains that have been shown to interact with Atoxl are MBD2 and MBD4
(van Dongen et al., 2004). MDB4 interaction with Atoxl is, however, much stronger than
that of MBD2 (van Dongen et al., 2004). We are therefore interested in knowing how
WDS-6 acquires Cu and how the 2 disease causing mutations in WD5-6 affect Cu this
process. We propose here that WD5-6 has a ferrodoxine-like fold and that WD4 is a
possible Cu donor for WD5-6.

Objectives ofthis study

In this study we focused on cloning, expression, purification and characterization
of WD5-6 using various spectroscopic and chromatographic techniques. The other
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objectives of this study were to elucidate of solution NMR structure of WD5-6 and to test
interactions between WDS-6 with metallated WD4 and Atox I by NMR titration.
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CHAPTER II
EXPERIMENTAL METHODS
Materials
All the pnmers were purchased from Integrated DNA Technologies, Inc. All
restriction endonucleases, other enzymes and their buffers were purchased from New
England Biolabs Inc. and Life Technologies. The nucleotides and citric acid were
purchased from Sigma Chemicals Co., while the bacterial strains and plasmids were
obtained from Novagen. The QIAGEN plasmid DNA isolation kit was purchased from
Qiagen Inc. Dimethylsulfoxide (DMSO) and dibasic potassium phosphate were
purchased from J. T. Baker Chemical Co. lsopropyl-�-D-thiogalactopyranoside (IPTG)
was purchased from !NALCO SPA (Milano, Italy).
Sodium chloride, ammonium sulfate, 2-(4-Morpholino)-ethane sulphonic acid,
dextrose, yeast extract, thiamine hydrochloride and sodium phosphate (mono- and
dibasic) were purchased from Fisher Chemicals. Deuterium oxide (D20) was obtained
from Aldrich, tris-(2-Carboxyethyl)-phosphine hydrochloride (TCEP.HCI) used as a
reducing agent during fluorescence experiments was bought from Pierce, Bio-Rad dye for
determination of protein concentration from Bio-Rad Laboratories Inc., Agarose from
Gibco BRL, Kanamycin sulphate recombinant plasmid screening from Calbiochem and
Bacto-Agar from DIFCO laboratories. PES (polyether sulfone) filter (0.22 µm) used to
filter the extracted protein were purchased from Coming Inc. Stirred Ultra-filtration Cells
obtained from Amicon Bioseparations while NMR tubes were bought from WILMAD
LabGlass.

24
Cloning of WD5-6 gene

To produce WD5-6, tire gene coding for WD5-6 protein was amplified by PCR
from cDNA copy, digested by restriction enzymes then inserted into an appropriate
expression vector. The recombinant plasmid is transformed and induced in E. coli cells
for protein expression.

Primer design
Forward primer, 5'-CAA CCA GAG rcA TGG CAC CGC AGA AG-3', was
designed to include a start codon ATG (Met) and a unique restriction site for Nco1
(CCATGG) while the reverse primer, 5'-GAG CGT TGG GAT CCT ACT GGG CCA
GGG-3', was designed to include a stop codon (ACT) and a unique restriction site for
BamHl (GGATCC). The primers were used to amplify the gene coding for WD5-6 from
human cDNA for full length wild type template of Wilson's disease protein using
polymerase chain reaction (PCR) thermal cycling.

Amplification of WD5-6 gene by PCR
The gene encoding WD5-6 was amplified by PCR thermal cycling using the
following program: (1) initial melting of the template DNA at 95 ·c for 5 min so that it is
denatured into two strands, (2) annealing step at 65 ·c for 1 min so that primers can
hybridize to the template DNA strand, (3) extension of primers by the DNA polymerase
at 72 ·c for 40 sec (4) denaturing at 95 ·c for 40 sec, (5) annealing at 65 ·c for 1 min (6)
extension at 72 'C for 1 min. Steps 4-6 were repeated 28 times then stored at 4 'C for 24
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hours. Annealing temperature (Tm ) was calculated from the composition of the primers
according to Wallace rule (equation 2.1)

Tm (in °C) = [(G+C) x4 + (A+T) x2]

2.1

PCR product was then purified by QIAquick Spin PCR Purification Kit (Qiagen,
Inc.) in three principle steps which includes; binding of the DNA to a column, washing
and finally eluting in an elution buffer by use of microcentrifugation according to the kit
instructions from the manufacturer. The size of purified DNA was determined by running
the purified PCR product on a 2% agarose gel alongside 100 base pairs DNA marker for
1 hour at 70 volts. The gel was stained with ethidium bromide for 20 min then visualized
under UV light. The size and concentration of the desired protein was determined by
comparing it to the standard DNA markers according to manufacturer's instructions.

Construction of an expression vector for WD5-6
An expression vector for WD5-6 gene was prepared by ligating WD5-6 insert
digested by Ncol and BamHI restriction enzymes to similarly digested pET24d+ to form
a recombinant expression vector, pDA WD5-6. The ligation was achieved by use of ligase
°

°

enzyme at l6 C for 8 hours. Heat-bar in a 4 C cooler was used to maintain a constant
temperature. The ligation products were analyzed by 1% agarose gel electrophoresis.
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Amplification and analysis ofthe recombinant plasmid

To amplify the WD5-6" recombinant plasmid, the plasmid was transformed into E.
coli cells, grown in LB media then isolated as described below.

Transformation ofpDAWD5-6 into DHa5 cells
The recombinant plasmid was maintained in E. coli DH5a host cells. Two
aliquots ofDH5a cells were thawed on ice before addition of3 µL ofdimethylsulfoxide
(DMSO). Undigested pET24d+ was added to the positive control tube, 2 ng ofdouble
digested pET24d+ was added to the first negative control tube, 2 ng ofrecombinant
plasmid to the experimental tube and nothing was added to the second negative control
tube. The cells were incubated on ice for an additional 30 min then subjected to heat
°

shock at 42 C for 1 min. After heat shock, they were incubated on ice for l min then
resuspended in 1 mL LB media containing no antibiotic. They were then incubated at
°

37 C and rotated at 250 rpm shaker for 1 hour. Finally the cells were centrifuged at
14,000 rpm for 1 min using a microcetrifuge, resuspended in 0.2 mL ofLB and plated out
on LB plates containing 30 µg/mL ofkanamycin. After 20 min, the plates were put in a
°

37 C incubator for 12 hours.

Inoculation oftransformed cells
A single colony from the experimental plate was aseptically picked and
introduced into 5 mL ofLB culture containing 30 µg/mL ofkanamycin. The culture was
then incubated at 37 °c and rotated at 250 rpm until the optical density at 600 nm (OD600)
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reached I. The cells were pelleted at 14,000 rpm for 2 min using a microcetrifuge.
Plasmid DNA was recovered and purified using a plasmid recovery kit from Qiagen Inc.

Analysis of recovered plasmid
The purified recovered recombinant plasmid w�s first ran on a I% agarose gel to

.

-'

ascertain the size, then subjected to restriction analysis and sequencing to confirm if the
insertion was successful. Restriction analysis was done by digesting the recombinant
plasmid with BamHl and Bglll restriction enzymes for 12 hours at 37 °c then the
fragments were run on a 1.5 % agarose gel to determine the size of the excised piece.
Gene sequencing was done in Dr. Barkman's laboratory to that the correct sequence was
obtained.

Induction of WD5-6
Having confirmed the insertion of the WD5-6 gene into the expression vector, an
induction test was set up to evaluate whether the recombinant plasmid could be induced
to produce the protein of interest in E. coli cells. The plasmid was transformed in BL2l
(DE3) cells by the same procedure used above then plated on LB agar plates containing
30 µg/mL kanamycin sulfates. Undigested pET24d+ vector was used as the positive
control while double digested pET24d+ was used as negative control. A single colony
from the experimental plate was inoculated into 5 mL of LB medium containing 30 µg/ml
kanamycin sulfate then incubated in a shaker set at 37°C and rotated at 250 rpm uhtill an
OD6oo of approximately 0.6 was reached.
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The culture was pelleted by centrifugation then resuspended in l 00 mLofLB
medium containing 30 µg/mLofkanamycin. The culture was incubated as described
before. At OD600 = 0.45, protein production was induced by addition ofl mM isopropyl
beta-thiogalactopyranoside (IPTG). The change in OD600 was monitored every 30 min
and each time a 0.5 mLsample was withdrawn, centrifuged and later loaded onto a 15%
tricine sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) in a Hoefer SE 250
mini-vertical gel electrophoresis unit. The pellets were first treated with 5 µLofloading
buffer and 20 µl ofwater then heated at 92 °c for 5 minutes before loading onto the gel.
The gel was run at 72 V for 1 hour then stained with coomassie blue strain for four hours.
The gel was destained, and then dried using a mini gel drying system from Invitrogen.

Overexpression ofWD5-6

Having shown that induction ofthe WD5-6 protein in DE3 cells was efficient, it
was then overexpressed in 10 LofLB medium. A fresh colony ofBL21 (DE3) cells
transformed with pDAWD5-6 recombinant plasmid was inoculated in 5 mLLB media
containing 30 µg/ml ofkanamycin and grown in a 3 7°C incubator to an OD600 ofabout 1.
The culture was pelleted, then resuspended in 100 mLLB containing the same
concentration ofkanamycin and grown to the same OD600. This was used as a starter
culture to inoculate 10 LLB. This big batch culture ofBL21 (DE3) transformed with
pDA WD5-6 was grown aerobically in a Microferm Fermentor (New Brunswick
Scientific Co.) to an OD600 of0.45 before WD5-6 expression was induced with 1 mM
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IPTG. After 3 hr the cells were harvested by centrifugation at 6000 RPM for 15 min
using a SLA 3000 rotor. The cell pellets was stored at -20 °C prior to protein extraction.

WD5-6 extraction and purification

WD5-6 extraction

•}

Protein extraction was done by treating the cell pellets with three successive
cycles of 10 min freezing in liquid nitrogen and 15 min thawing at 25°C. The pellet was
resuspended in 240 mL of freeze-thaw extraction buffer (20mM MES/Na, pH6, 0.1 mM
EDTA, lmM dithiothreitol (DTT)) then incubated on ice for 1 hr with periodic gentle
agitation followed by centrifugation at 6000 rpm for 15 min using a SLA-3000 rotor at
4°C. The supernatant was vacuum filtered through a 0.22 µm filter then stored at -20 °C.
The WD5-6 protein was purified in two chromatographic steps; Ion exchange and gel
filtration chromatography.

Ion exchange chromatography (IEC)
The WD5-6 extract was thawed on ice then loaded onto a pre-equilibrated DEAE
Sepharose column (Pharmacia, 2.6 cm X 13 cm, 69 mL). The protein was eluted with a
linear NaCl gradient using two buffers; (a) 20mM MES/Na, pH6, 0.1 mM EDTA, 5mM
DTT and (b) 20mM MES/Na, pH6, 0.1 mM EDTA, l M NaCl, 5mM DTT. Every 3rd
elution fraction was tested for protein content by Bio-rad protein assay. The WD5-6
protein containing fractions were identified by SDS-PAGE. All the WD5-6 containing
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fractions were pooled and concentrated using an Amicon device fitted with an YM-3
membrane.

Size exclusion chromatography (SEC)
The concentrated protein solution was loaded onto a superdex-O75 26/60 Hi-Load
- ,'

column (Amersham Biotech) attached to fast protein liquid chromatography (FPLC) and
eluted with a 20 mM MES/Na, pH 6.0, 150 mM NaCl, 10 mM DTT buffer. DTT was
included to ensure WD5-6 is reduced and running as a monomer. The elution was
monitored by UV spectrophotometry. Biorad protein assay was used to test for protein
containing fractions while SDS-PAGE was used to evaluate the purity of the WD5-6. The
fractions containing WD5-6 were pooled together and concentrated by an Amicon device.
°

Concentrated WD5-6 protein solution was stored in 0.2 mL aliquots at -80 C.

Isotopic labeling of WD5-6

Solving solution NMR structures of large proteins requires higher dimensional
NMR experiments (2D and 3D) that can only be achieved by isotopically labeled
proteins. Isotopic labeling was done to produce proteins uniformly labeled with 13C
and/or 15N for solution structure determination by NMR. The same expression vector and
host cells used for the unlabeled protein were employed but this time cells were grown in
minimal media. An induction test similar to the one described above was done in minimal
media supplemented with unlabeled dextrose and ammonium chloride as the sole glucose
and nitrogen source respectively. 1 5N Labeled WD5-6 was produced by growing BL21
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(DE3) cells transformed with pDA WDS-6 in 2 L of minimal media supplemented with
[ 15N]-ammonium chloride. The minimal medium(MNa2HPO4, 3g/L KH2PO4, 0.5g/L NaCl, l .0g/L

15

15

N) used consisted of 6g/L

NH4Cl, 0.4% glucose (w/v), 2mM

MgSO4, 0.1 mM CaCband 80 µl of I 0% thiamine.
The procedure for protein expression was as follows; A 5 mL culture of BL21

..

(DE3)/pDA WDS-6 was grown to saturation in LB containing 30 µg/ml of kanamycin
sulfate. The 5 mL culture was centrifuged and the cell pellet was resuspended in 2 L of
M- 15N in a SL fermetor flask. The cells were grown at 37°C to an OD600 of 0.45, the
point at which protein expression was induced by addition of 1 mM IPTG. The cells were
harvested 4 h later. The protein was isolated by the freeze thaw method and purified by
same methods used for the unlabeled protein. The double labeled protein,
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N and

13 C

labeled WDS-6, was produced by expressing the pDAWDS-6 recombinant plasmid in a
media consisting of 6g/L Na2HPO4, 3g/L KH2PO4, 0.5g/L NaCl, l.0g/L 1 5NH4CI, 0.4%
2mM MgSO4, 0.1 mM CaCb, 80 µI of 10% thiamine and 0.4% 13C- glucose (w/v) as the
sole carbon source.

Determination of WDS-6 protein concentration

WDS-6 concentration was first determined by the Bradford protein assay (Biorad)

and UV absorption methods. For the Biorad assay, a calibration curve was prepared by
plotting increasing concentrations of immunoglobulin G (1.5 to 25 µg/mL) (IgG) versus
the corresponding absorption at 595 nm. The resulting equation of the line was used to
calculate the concentration of the purified WDS-6 protein. UV absorption measurement
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was done at 276 and at 280 nm using molar absorptivity constant of 4350 M- 1 cm- 1 and
4080 M- 1 cm- 1 respectively. The molar absorptivity constants were derived from amino
acid sequence analysis by the ·ProtParam program (Expassy website). Four µL of WD5-6
protein was diluted to 200 µL using 20 mM sodium phosphate, 6M guanidium chloride,
pH 6.5 buffer in clean narrow path quartz cuvette. The UV absorption measurement was
then taken at 276 and 280 nm. Concentration by the UV method was determined by
equation 2.2 below.
AxDF
c=---

2.2

&Xb

Where c is the protein concentration in moles per liter, A is the UV absorbance at a given
wavelength, b is the light path-length in cm, DF is the dilution factor and Eis molar
absorptivity constant.

Amino acid hydrolysis
Amino acid hydrolysis analysis of WD5-6 was performed at the Protein
Chemistry Laboratory at Texas A&M to determine its exact concentration and
composition. Two µL of WD5-6 stock solution was desalted and resuspended in 20 mM
MES/Na, pH 6 before use in the experiment. Total amino acid hydrolysis was used to
analyze WD5-6.

Isoelectric point determination

The isoelectric point (pl) of WD5-6 was determined using pH 3-9 gradient gels on
a Pharmacia PhastSystem employing the Broad Range pl calibration kit from Amersham
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Pharmacia Biotech. Isoelectric focusing consisted of three steps: a prefocusing step (2000
V, 2.5 mA, 3.5 W for 75 volt hours), a sample application step (200 V, 2.5 mA, 3.5 W for
15 volt hours and a focusing step (2000 V, 2.5 mA, 3.5 W for 410 volt hours. About 2 µg
of protein was loaded. The broad range pl calibration kit from Amersham Pharmacia
Biotech was used.

. ,'

IEF gels were stained manually in four steps: (i) fixing the gel with 20%
trichloroacetic acid for 10 min at room temperature, (ii) rinsing with 10% acetic acid and
30% methanol solution for 2 min at room temperature, (iii) staining with 0.02%
Coomassie Brilliant Blue, 0.1% copper (II) sulfate, 10% acetic acid and 30% methanol at
50 ·c for 20 min and (iv) destaining with 10% acetic acid and 30% methanol solution at
50 ·c. The gel was air-dried then scanned. A standard curve was formed by plotting
distance migrated by the standard proteins versus their pis. The resulting equation of the
line was used to calculate the pis of samples based on the distance they migrated in the
gel.

Determination of the MW and aggregation status of WD5-6

MW and aggregation status of WD5-6 were determined by mass spectrometry,
high resolution gel filtration and laser light scattering methods.

MALDI mass spectrometry
Matrix Assisted Laser Desorption Ionization (MALDI) mass spectrometry was
used to determine the molecular mass of WD5-6 at Michigan State University. Two µL of
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purified W5-6 solution (0.9 mM) was used for the experiment. The mass spectrometry
experiment was done using a JEOL AX-505 double focusing mass spectrometer. ·

High resolution gel chromatography (HRGC) analysis
Apparent MW and aggregation status of WD5-6 were determined by HRGC
analysis and HPLC size exclusion laser light scattering. A calibration curve was prepared
by (i) measuring the elution volumes of standard proteins; Ribonuclease A (MW=
13,700 Da), Chymotrypsinogen A (MW= 25,000 Da), Ovalbumin (MW= 43,000 Da)
and Albumin (MW= 67,000 Da), (ii) calculating their corresponding Kav (elution
parameter) values and (iii) plotting their Kav values versus the logarithm of their
molecular weight. Fifty µL of 164 µM apo-WD5-6 was reduced by addition of l O mM
DTT, incubated on ice for 10 min, and then injected into a HR 10/30 column (Amersham
Pharmacia Biotech). WD6 was used as a control.
The HRGC column, Superdex G 75 10/30 (Pharmacia), was pre-equilibrated with
20 mM MES/Na, pH6, 150 mM NaCl and 10 mM DTT buffer. The sample was eluted in
same buffer as the standards at a flow rate of 0.5 mL/min. The retention volume was then
compared to a calibration curve previously prepared. Dextran Blue 2000 dye was used to
determine the void volume (V0) of the column.

Laser light scattering of WD5-6
Most of the methods used to characterize the WD5-6 protein required accurate
determination of its MW and aggregation status. Theoretically, the amount of laser light
scattered is proportional to the product of molecular mass of the protein and its
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concentration (mg/mL) in laser light scattering experiment. Molecular weight (MW) and
aggregation status of WD5-6 was determined by a high performance liquid
chromatography (HPLC) size-exclusion laser light scattering experiment that was done at
the Yale Keck Biophysics Facility. The Superdex 75 HR 10/30 column (Pharmacia) for
size exclusion chromatography was connected on-line with the following detectors; a
Waters 996 Photodiode array multi-wavelength UVNIS detector (Waters), a DAWN
DSP LS detector (Wyatt Tech.) and an OPTILAB DSP RI detector (Wyatt Tech.). The
system was calibrated using 5 proteins ( cytochrome c, Carbonic anhydrase, ovalbumin,
bovine serum albumin and alcohol dehydrogenase) whose MWs extend from 12.4 kDa to
147 kDa.
The MW of WD5-6 was determined from the absolute measurement of scattered
light intensity measured at 18 different angles. Comparison of the UV/RI signal ratio
across the peaks of interest provided information relating to the homogeneity of the
sample. Measurement was done at two concentrations and MW was calculated using
ASTRA software.

Metal binding and transfer experiments

These experiments were performed to establish the copper: WD5-6 binding
stoichiometry and whether copper transfer can occur between WD5-6 and WD4. In
determining binding stoichiometry, two methods were used; (i) titrating a Cu(I) solution
into a WD5-6 solution containing a reducing agent and (ii) metallation of a known
amount of protein with Cu, washing the unbound Cu in an Amicon ultra-filtration device

36
then running on HRGC column. The peak fraction was collected and analyzed for Cu and
protein content by Biorad protein assay and ICP-MS respectively.

Preparation of 1 M sodium phosphate buffer, pH 7.2
The sodium phosphate buffer was prepared by mixing 140 mL of 2 M monobasic
phosphate solution with 360 mL of 2 M dibasic phosphate then diluting to IL with
distilled water (dH20). Two molar monobasic phosphate was prepared by dissolving 69 g
of monohydrate sodium phosphate (Formula weight, FW, = 137.99) in 160 mL of
distilled water then the solution was brought to 250 mL with dH20. On the other hand, 2
M dibasic phosphate solution was prepared by dissolving 141.96 g of anhydrous
disodium hydrogen phosphate (FW = 141.96 g) in 300 mL of dH20 then bring it to
volume with to 500 mL with dH20.

Preparation of 10 M guanidium chloride 0. lM sodium chloride solution
Guanidium chloride is the commonly used chemical to denature proteins in
solution. Sodium chloride is included to enhance the ionic strength and to stabilize the
denatured state of protein. One hundred mL of 10 M guanidium chloride (FW = 95.53 g),
0.1 M NaCl (FW = 58.44g) solution was prepared by dissolving 95.53 g of guanidium
chloride and 0.5844 g of NaCl in 50 mL dH20 then brought to volume with dH20.

Preparation of WD5- 6 sample
Protein concentration was calibrated and estimated by the total amino acid hydrolysis
data from Texas A&M. A known amount was measured out, reduced by addition of 4
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fold DTT, degassed, filled back with nitrogen then transferred into a V AC vacuum
· atmosphere anaerobic chamber: The sample was exchanged in 0.1 M sodium phosphate
buffer pH 7.2.

WD5-6 metal binding experiment
•;

A portion of the WD5-6 sample prepared above was mixed with excess Cu (I)
solution, incubated for 10 minutes and then exchanged in 0.1 M sodium phosphate buffer
to get rid of excess metal. The final sample was brought out of anaerobic chamber and
run on a Superdex G75 HR column. The peak fraction was collected and analyzed by
ICP-MS for copper content. Protein concentration was determined by Biorad protein
assay. Binding stoichiometry was estimated from the ratio of final protein and copper
concentration. The experiment was done in triplicate.

Analytical gel filtration of WD5-6 and WD4
This preliminary experiment was done to establish the high resolution gel running
properties of WD5-6 and WD4, and to gauge the suitability of using this method to
monitor metal transfer between WD5-6 and WD4. WD5-6 has a MW of 16,049 D while
WD4 has a molecular mass of about 7 KD and this is a good basis to separate them by
HRGC. The Cu(I)WD5-6 and WD4 were prepared adding 10-fold DTT to a dilute (0.10.5 mM) protein solution in 0.1 M sodium phosphate buffer at pH 7.2 followed by 2 fold
excess of CuSO4 solution. The protein solution was concentrated and washed with buffer
containing 2 mM DTT as appropriate to achieve a 2-fold DTT: protein ratio in the
sample.
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The HRGC column was first equilibrated using 20 mM MES/Na pH 6.0, 150 mM
NaCl buffer. The samples were then injected into the column and run at a flow rate of 0.5
mL/min. Elution volumes were recorded. Three blank runs were done before actual
samples to ensure the column was in good shape. Samples injected were apo and Cu (I) WD5-6, apo and Cu(l)WD4, and a combination of WD5-6 and WD4. Both the apo and
metallated proteins were run to ensure metallation doesn't shift the elution peak.

Circular dichroism experiment

A circular dichroism (CD) experiment was used to probe a-helicity of WD5-6. A
WD5-6 solution was prepared by reduction in 100 mM DTT and then exchanging in 0.25
mM sodium phosphate, pH 7.2 buffer under anaerobic conditions. The final sample had a
concentration of 1.56 µM WD5-6. A 10 mm jacketed cell was thoroughly cleaned and
dried before samples were introduced. The spectropolarimeter was attached to a nitrogen
generator flow from oxidation by atmospheric oxygen. Temperature was set and
maintained at 25 ·c by running water through a jacketed cell. After I hr of incubation the
samples were scanned, starting with the blank, at a rate of 2 nm per second over the far
UV range of 190 nm to 260 nm. CD spectra were collected on a J-715 spectropolarimeter
(JASCO, Japan) fitted with a 150 W Xenon lamp. The spectrum was corrected for
background noise.
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Chemical unfolding experiment

This was a preliminary experiment done to determine the UV absorption and
emission properties of WD5-6 and to establish whether emission spectroscopy can be
used to study unfolding of this protein. An apo-WD5-6 sample was prepared by
exchanging it with a 0.1 M phosphate buffer, pH 7.2 and then adjusting to a final
concentration of 31.2 µM WD5-6. Five mM tris-(2-carboxyethyl)-phosphate
hydrochloride (TCEP-HCL) was added to the final sample to keep it reduced. All the
buffers, solutions and water used for this experiment were vacuum-filtered through a 0.22
µm membrane and covered to avoid dust contamination. The instrument was blanked
with 0.1 M sodium phosphate buffer, pH 7.2.

Emission measurements
The samples were excited at 278 nm. A bandwidth of 5 nm was used both for
excitation and emission. The emission spectrum was recorded between 290 nm and 400
nm. Different concentrations of guanidium chloride for the denaturing experiment were
prepared as shown below (Table 1). The samples were first incubated for 20 min then
measured starting with the blanks in the order of increasing concentration of guanidium
chloride. The cell was thoroughly cleaned and dried before measurements begun. The
cells were carefully rinsed between the measurements.
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Samples
l
2
3
4
5
6

IM Sodium
phosphate buffer
100
100
100
100
100
100

10 M Guanidium
chloride/0. l NaCl
0
0
200
400
600
800

dH2O
895
890
690
490
290
90

0.312 mM
WDS-6
0
5
5
5
5
5

lM
TCEP.HCI
5
5
5
5
5
5

+ ,.

Table 1. Preparation of WDS-6 samples with different guanidium chloride concentration.
The amounts are in µL of ingredients used in the fluorescence unfolding experiment.
Sample 1 is the sodium phosphate buffer blank while the sample 2 is for the WDS-6
blank (without the denaturant).
NMR spectroscopy

The strategy used for the determination of solution NMR structure of WDS-6
involved careful preparation of unlabeled and labeled protein solutions, spectra
acquisition, spins system and sequential resonance assignment, collection of
conformational constraints and calculation of the 3D structure. Spin system resonance
assignment identified which proton resonance belonged to which residue type while
sequential resonance assignment showed which proton belonged to which residue in the
WDS-6 protein sequence. The calculated NOE and ]-coupling NMR constraints were
used to identify which protons were close in space and what the torsion angles were. The
structure calculated represents conformation(s) consistent with all the NOE, J-coupling
and other constrains. The reported structure is a mean of an ensemble of 20 lowest energy
structures of the protein calculated from the collected data.
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NMR sample preparation
Protein sample preparation is a very important step in NMR experiments. The
purity, MW and aggregation status of WD5-6 were confirmed by various methods
described above. Six hundred and seventy µL of a 0.9 mM WD5-6 stock solution was
aliquoted, reduced by addition of excess DTT, degassed, filled back with nitrogen, then
transferred into a V AC anaerobic atmosphere nitrogen chamber. The sample was
thoroughly degassed because oxygen is both paramagnetic and an oxidizing agent.
Paramagnetic elements such as oxygen lead to broadening of the lines of the NMR
spectrum. Being an oxidizing agent, oxygen may lead to formation of disulfide bonds
and/or chemical damage of the protein. The sample was then desalted by exchanging in
0.1 M sodium phosphate buffer pH 7.2 using an Amicon device fitted with a YM-3
membrane to reduce the concentration of OTT to about 2 mM.
The protein solution was then concentrated to 540 µL. Sixty µL of deuterium
oxide was added to make 600 µL of l mM WD5-6 (10% D20) solution. The sample
concentration was estimated by the Biorad protein assay before loading into high quality
NMR tube. The tube was capped with septum cap, brought out of the anaerobic chamber,
packed and shipped to CERM, Italy for NMR analysis. All these manipulations were
carried out anaerobically in a glove box with de-oxygenated buffers and solvents. This
procedure was repeated for single and double labeled WD5-6 samples. The final protein
concentration was about 1 mM.
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NMR experiments
All NMR experiments were performed at the Magnetic Resonance Center
(CERM), University of Florerrce, Italy. WD5-6 NMR spectra were acquired on Avance
900, 800, 600 and 500 Bruker Spectrometers operating at a proton nominal frequency of
900.13 MHz, 800.13 MHz, 600.13 MHz and 500.13 MHz respectively. All 2D and 3D
spectra were collected at 298 K, processed using the standard Bruker software
(XWINNMR) and analyzed using the CARA program.

1

H. 15N-Heteronuclear single quantum coherence (HSOC) experiment
The 1 H, 15N- HSQC experiment is a two dimensional (2D) experiment with one

1

H frequency and one 15N frequency. Each of the naturally occurring amino acids (except

proline) gives one signal on 1 H, 15N- HSQC spectrum which corresponds to the N-H
amide group. The 1 H, 15N-HSQC experiment correlates the nitrogen atom of an NHx
group with the directly attached proton. Each signal in a HSQC spectrum represents a
proton that is bound to a nitrogen atom. The spectrum contains the signal of the HN
protons in the protein backbone and since there is only one backbone HN per amino acid,
each HSQC signal represent one single amino acid.

NMR Titrations of WD4 and WD5-6 domains
These experiments were performed to monitor transfer of copper from Cu(l)WD4
and Cu(I)Atoxl to WD5-6. 15N labeled apoWD5-6 was titrated with unlabelled
Cu(l)WD4 and unlabeled Cu(l)Atoxl separately using NMR spectroscopy to follow the
15

N- 1 H spectral changes upon addition of the unlabelled metallated protein partner.
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Small amounts of metallated unlabeled proteins were added to the labeled samples in the
NMR tube using a Hamilton syringe. Additions were done in a Coy chamber under
nitrogen atmosphere at 298 K:-- The metallation of WD5-6 was monitored through 15N- 1 H
spectral changes of valine 19 and valine 95 residues.

.-

Resonance assignment and structural restraints
1

H - 1H distances and the dihedral angles (cp and \If) were determined through

nuclear overhauser effects spectroscopy (NOESY) and HNHA experiments. H-bond
constraints were obtained using transverse relaxation optimized spectroscopy (TROSY)
version of the long range HNCO experiment at a magnetic field of 800 MHz. Relaxation
experiments were performed on a Bruker Avance 600 MHz NMR at 298 K. The WD5-6
structure and folding was calculated from the constraints derived from these experiments.

Relaxation rate measurements
The Relaxation experiments were performed on Bruker Avance 600 MHz or 500 MHz
spectrometers at 298 K. 15N R1, R2, and steady-state heteronuclear 1H-15N NOEs were
measured with pulse sequences as described by Farrow et al 51• Integration of cross peaks
for 15N R 1, R2, and 1H- 15N NOEs spectra was performed by using the standard routine of
the XWINNMR program. Relaxation rates R 1 and R2 and heteronuclear NOE values were
determined following a standard procedure as reported previously (Amesano et al.,
2001). The experimental relaxation rates were used to map the spectral density function
values, J(mH), J(mN), Je fl(0), following a procedure available in literature (Peng &
Wagner, 1992), in order to investigate the backbone motions (Peng & Wagner, 1992). An
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estimate of the overall rotational correlation time was derived from the measured R2/R1
ratio by using a standard procedure (Kay et al., 1989; Pervushin et al., 1997)

;
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CHAPTER III
RESULTS
Cloning of WD5-6
The portion of the WDP gene encoding for the N-terminal metal binding domains
5 and 6 (residues 485-633) was amplified from a human cDNA plasmid encoding full
length WDP through 28 PCR cycles in a MiniCycler (MJ Research) employing Deep
Vent DNA polymerase (New England Biolabs). The human cDNA plasmid was
generously donated by Dr. Gitlin of Washington University, St. Louis, Missouri. PCR
products were purified, double digested with restriction endonucleases Ncol and BamHl
then cloned into an E. coli expression vector, pET24d+. The recombinant plasmid was
maintained in DH5a cells.

1000 bp

500 bp

100 bp

Figure 6. Agarose gel electrophoresis of WD5-6 recombinant plasmid digests on a 1.5 %
gel. In Janel , is a band of the WD5-6 gene from a recombinant plasmid digestion (500
bp), in lane2, 100 bp marker.
Cloning was verified by sequencing of the gene in Dr. Barkman's lab and also by
restriction analysis of the recovered plasmid employing BamHl and BglII restriction
enzymes. The sequence of the insert matched perfectly with the native sequence for this
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portion of the gene. The alignment was done using the DNA Strider program. Band
representing a fragment of DNA slightly below 500 base pairs (bp) was seen on a 1.5%
agarose electrophoresis gel ofthe doubly digested recombinant plasmid (Figure 6). This
confirmed that DNA of the right size was successfully inserted into the expression vector,
pET24d+.
...,"'f

Induction of WDS-6 in LB media
The time course induction of WDS-6 protein was done to test whether WDS-6
could be efficiently expressed in LB media containing 30 µg/L of kanamycin. The
recombinant plasmid was transformed into E.coli [BL21 (DE3)] cells and induced for
WD5-6 protein expression in LB medium. Kanamycin was used to select for cells
transformed with the recombinant plasmid because the plasmid contained genes for
kanamycin resistance. The growth of the cells was monitored by measuring optical
density at 600 nm (OD600). WD5-6 expression was induced at OD6oo of 0.45 by addition
of 1 mM IPTG. IPTG binds and inactivates the lac operon repressor and hence induce
WD5-6 gene transcription by RNA polymerase. The OD6oo reading was taken every 30
min for 4 hours after induction and each time a 0.5 mL sample was withdrawn,
centrifuged and analyzed on SOS-PAGE gel for WDS-6. The loading on SOS-PAGE was
normalized by the OD600 reading using equation 3.1.

OD6oo at time Ox 15 µl
OD6oo at time ti

3.1
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The results showed a steady increase in cell density with time as was reflected by
the OD600 (Table 2). This indicated that the bacterial cells growth was not hampered by
addition of IPTG. The normaHzed loading on SDS-PAGE showed increase in intensity,
with time, of a protein band of about 16 kDa believed to be of WD5-6 protein (Figure 7).
This is a clear indication that induction and the expression system for WD5-6 worked
well. A 10 L batch was planned to produce WD5-6.
Time (min)
0
30
60
90
120
150
180
210
240

OD6oo
0.4752
0.7086
0.8325
0.9667
1.0700
1.1900
1.2730
1.3560
1.4040

Normalized loadin2:( uL)
15
10.1
8.6
7.3
6.7
6.0
5.6
5.3
5.1

Table 2. Time course induction of WD5-6 protein showing steady increase in OD6oo with
time. The last column shows the amounts normalized by OD6oo for loading on SDS
PAGE.
M

0

30

60 90

120 150 180 210 240 min

45kD30kD20kD-

WD5-6

Figure 7. SDS-PAGE gel for time course induction of WD5-6 protein. The WD5-6 band
of 16 kDa increases steadily with time.Mis the Rainbow protein marker (RPN 755)
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WD5-6 10 L batch production
Having shown that the WD5-6 protein is efficiently expressed by the designed
WD5-6 expression system, a i 0 L batch was produced in LB media containing same
concentration of kanamycin following the protocol outlined earlier. The aim was to
produce WD5-6 protein in sufficient quantities for char_acterization. The cells were

. ,·

pelleted by centrifugation then used for WD5-6 protein extraction by the freeze-thaw
method. After harvesting and extraction, the WD5-6 crude extract was analyzed by
SDS-PAGE. A strong band on SDS-PAGE gel of about 16 kDa, which is molecular mass
of WD5-6, showed that WD5-6 protein was expressed well in the 10 L batch (Figure· 8).

U

21to
MO

•

7.S

50

2..5

1- WD56

Figure 8. Tricine SDS-PAGE (15%) of freeze-thaw extracted WD5-6. Lanes 1; Mis
protein markers, 10, 7.5, 5.0 and 2.5 are different amounts (in µL) of WD5-6 extract
loaded on the gel.
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WD5-6 purification

WD5-6 was successfully extracted using the freeze-thaw method and isolated by a
two step purification scheme involving anion exchange chromatography and gel filtration
chromatography..

. .-

Ion exchange chromatography (IEC)
The WD5-6 extract was filtered then loaded onto a pre-equilibrated DEAE
Sepharose CL-6B anion exchange column (Amersham Pharmacia Biotech) in order to
isolate it from the other contaminating proteins. Proteins that bear negative charge at pH
6 bind to the positively charged DEAE resin while the neutral and positively charged
ones flow through without binding. The degree to which each protein binds to the column
partially depends on the charge on the protein. Those that bind weakly are eluted first at
low ionic strength while those that bind strongly are eluted at higher salt concentrations.
WD5-6 has a pl of 4.87 and therefore bears net negative charge at pH 6 (pH of the buffer)
and was expected to bind to the DEAE Sepharose anion exchange column.
Protein elution was monitored by the UV absorption profile at 254 nm.
Polypeptides absorb UV light strongly around this wavelength. The resulting fractions
were also analyzed by Biorad protein assay to identify protein containing fractions and
also to estimate protein concentration (Table 3). SDS-PAGE analysis was used to identify
WD5-6 containing fractions (Figure 9). SDS-PAGE separates proteins based on size; the
smaller proteins experience less resistance in moving through the gel pores compared to
the larger ones and therefore move faster through the gel. To estimate the protein sizes
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more accurately, a set of protein standards of know MW were also ran alongside the
samples.

IEC Fraction
number
35
39
41
46
50
52
59
71

Absorbance
at 595 nm
0.1718
0.3858
0.6176
0.8306
0.7809
0.8036
0.2881
0.0348

Concentration
(ug/mL)
229.3
506.87
807.52
1083.8
1019.3
1048.8
380.16
51.62

Table 3. Biorad protein assay for IEC fractions. The left column shows IEC fraction
numbers, the middle column show absorbance of fractions at 595 nm, while the right
column show the protein concentration in µg/mL calculated from the lgG standard curve.

M
21kD
14kD

__..

-

.

35

39 41 46

48

50 52

59

71

-wo5-6

Figure 9. SDS-PAGE ofIEC fractions. Mis the Rainbow low molecular weight marker,
35-71 are IEC fractions. WD5-6 band of about 16 kDa is present in fractions 41-59.
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The Biorad protein assay showed that all the peak fractions contained protein but
at varied concentrations. Fractions 41 to 52 had the highest concentration. SOS-PAGE
analysis was used to identify W05-6 containing fractions. Five µI were withdrawn from
each of the peak fractions, mixed with loading dye and water and run on a 15% Tricine
SOS-PAGE gel (Figure 9). The gel revealed that WD5-6 eluted in fractions 41 through

. ,-

59 which corresponded to about 30% salt concentration (0.3 M NaCl). The ion exchange
chromatography concentrated WD5-6 in fractions 46-59 but the SOS-PAGE revealed the
presence of other proteins of different molecular weights. To isolate WD5-6 further, a
method which can separate proteins based on size was required.

Size exclusion chromatography (SEC) of WD5-6
This purification step was used to fractionate the proteins based on their sizes.
The WD5-6 containing fractions from IEC were concentrated from 26 mL down to 2 mL
using an Amicon device fitted with a YM3 membrane. The concentrated protein solution
was loaded onto a Superdex G 75 10/30 gel filtration column(Amersham Pharmacia) pre
equilibrated with MES buffer (20 mM MES/Na, pH 6.0, 150 mM NaCl, 10 mM OTT).
SEC separates molecules based on size. Superdex G 75 separates molecules in the
range of 3 to 75 kDa. In SEC, the larger molecules elute first while the smallest in
column range elute last. UV absorption at 254 nm was used to monitor elution of proteins
(Figure 10). Biorad protein assay was used to identify protein containing fractions. The
WD5-6 containing fractions were specifically identified by SOS-PAGE. A single band of
about 16 kDa appeared on SOS-PAGE column where fraction 36 was loaded (Figure 11).
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WDS-6 Superdex Gel filtration
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Figure 10. UV absorption profile ofWD5-6 SEC elution. SOS-PAGE analysis revealed
that the peak marked WD5-6 corresponding to fractions 35-39 contained the pure WD5-6
protein.

M
-..1
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2JkD

l

WD5-6

Figure 11. SOS-PAGE of SEC fractions. M is the molecular marker. WD5-6 band is
shown on lane 7 where fraction 36 was loaded.

Fractions 35 to 39 under this peak were pooled together and concentrated down
using an Amicon device fitted with a YM3 membrane. The final WD5-6 concentration
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was determined using the Biorad protein assay, UV absorption spectrophotometry and
total amino acid hydrolysis.

Determination of the concentration of purified WD5-6
The purified WD5-6 concentration was determined by 3 different methods; the
Biorad protein ass-;;�, the UV absorption method and the amino acid hydrolysis method.
For the Biorad assay an IgG standard curve was prepared and used to calculate the
concentration of the WD5-6 protein. The binding of Biorad dye to the basic residues,
especially arginine, uniformly increases its light absorption at 595 nm. The equation of
the line for lgG standard curve was used to calculate the concentration of WD5-6 samples
measured in the same manner. Equation 2.2 was used to estimate WD5-6 concentration
by UV absorption method. The concentration of purified WD 5-6 was found to be 0.51
mM by Biorad assay while the UV method revealed a concentration of 0.61 mM. This
difference prompted use of total amino acid hydrolysis method to determine the
concentration of WD5-6.
The total amino acid hydrolysis found the concentration of WD5-6 to be 0.50 mM
based on the average of all the amino acid residues. The amino acid composition was
consistent with that of WD5-6 for all the amino acids except aspartate, asparagines,
glutamate, glutamine and cysteins (Table 4). The concentration determined by Biorad
assay was consistent with that of amino acid hydrolysis while that of UV absorption
method overestimated the concentration by 22%.
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Table 4. WDS-6 total amino acid hydrolysis result is consistent with its amino acid
composition. IS(!) and IS(2) are internal standards.
Molecular mass ofWD5-6

MALDI-MS ofWD5-6
The molecular mass ofWD5-6 was determined by Matrix-Assisted Laser
Desorption Ionization - Mass Spectrometry (MALDI-MS) at Michigan State University.
The theoretical MW ofWD5-6 is 16,049.5 Da. The MW determined by MALDI-TOF
+

was 16,095.34 Da and is possibly for WD5-6 plus 2 Na adducts (Figure 12). The buffer
in which WD5-6 was stored had 150 mM NaCl. This deviation ofMW by 0.24% is,
however, within accepted experimental error. The second peak at 15,961 Da represents
the MW ofWD5-6 minus MW ofmethionine, which 'is the first residue in the WD5-6
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amino acid sequence. The methionine residue was probably cleaved during excitation of
WD5-6. There is a peak at exactly halfthe mass ofthe parent peak and this represents the
doubly charged WD5-6.
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Figure 12. MALDI-MS spectrum ofWD5-6.

High resolution gel chromatography (HRGC) results for WD5-6
The molecular mass and aggregation status of WD5-6 was determined by HRGC.
A HRGC column was calibrated by running Dextran Blue 2000 to determine the void
volume followed by four standard proteins with known MWs (Figure 13). The void
volume (V0 ) was found to be 8.2 mL. Total column volume (V1) for this column is 23.56
mL. The Kav was calculated by the formula previously shown (Equation 2.3). WD5-6
and WD6 were run on the same column to determine their elution volumes that were used
to calculate their Kav by equation 3 .2 and molecular masses.
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V, -V0
Elution parameter, Kav = --'---V, -V-"--

3.2

o

Where Ye= elution volume fc:_>r the protein, Y0 = Column void volume, Y1 = total bed
volume.
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Ribonuclease A
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y = -2.4879x + 5.118
R2 = 0.9693
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Figure 13. HRGC calibration curve. The elution parameter, Kav was plotted versus the
logarithms of the MW of the standard protein to give a calibration curve from which the
masses of the samples were calculated.
Apparent MW Expected MW
Sample Ye(mL) Kav
0.2897 25,257
16,049
WD5-6 12.65
7,732
13,076
0.4
WD6 14.36
Table 5. Apparent running masses of WD5-6 and WD6 calculated from the HRGC.

The MW of WD5-6, as well as that of WD6, was overestimated by HRGC (Table
5). The apparent MWs were, however, less than those expected for dimeric forms of both
the proteins. The elution profile of WD5-6 showed a single Gaussian peak (Figure 14).
This showed that the WD5-6 solution is homogeneous and devoid of contaminants.
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Figure 14. A WD5-6 elution peak from HRGC showing a single peak that eluted at 24.4
min at a flow rate of 0.5 mL/min.
Laser light scattering experiment
This experiment was done to determine the aggregation status and molecular mass of
WD5-6. In this experiment, WD5-6 was first run on SEC column then detected by a laser
light scattering and UV/RI detectors at the end of the column. The amount of light
scattered is proportional to the product of size and concentration. The experiment was
done in duplicate at different concentration. The results obtained (Table 6) showed two
peaks which are clearly for WD5-6 monomer and dimer. The second peak of S 1 run
corresponded to the exact MW of WD5-6 (16.05 kDa) (Figure 15). WD5-6 dimer could
have resulted from oxidation while the sample was on transit to Yale. The UV/RI ratio
from the two peaks arising from different oligomers of WD5-6 remained unchanged for
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the two peaks throughout the chromatogram. That was clear indication that WD5-6 was
homogeneous
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Figure 15. Plot ofelution volume versus the molar mass of WD5-6. The S1 (green) and
S2 (purple) are duplicates runs but S2 is at halfthe concentration of S1 sample. The
ration of dimer to monomer is higher for S1 run and this could be due to higher
concentration. More concentrated protein solution easily dimerize by formation of
disulfide bonds. The molecular weight was calculated from data derived from the above
plot by ASTRA software ( Table 6).

Sl
S2

Run Peak
MW(kDa)
Elution at Calculated by
UV trace ASTRA
(mL)
(Average for the
entire peak)
10.60
29.92
12.12
16.05
31.2 2
10.60
12.14
16.32

MW (kDa)
Calculated by
ASTRA range
ofMW
observed
29-31
15-17
30-32
15-17

Sequence
predicted
MW for
monomer
(kDa)
16.05
16.05
16.05
16.05

Mono
disperse
peak
Yes
Yes
Yes
Yes

Table 6. The Laser light scattering results for WD5-6 protein showing two peaks for
each trial. The monomer peak of S1 trial corresponds exactly to the MW of WD5-6. The
MW corresponding to dimer was observed too for both trials.
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Isoelectric point of WD5-6

This experiment was done to determine the isoelectric point (pl) of WD5-6
protein. A calibration curve was prepared by running standard proteins alongside WD5-6
sample and WD1 as a control. The pl for WD5-6 was calculated from the standard curve
derived from a plot �f the pl of standard proteins versus the distance migrated from the
cathode on the isoelectric focusing gel. The distance migrated from the cathode in mm
was measured from the dried isoelectric focusing gel shown below (Figure16).

pl
9.30
6.GS
6.45
6.15
7.35
6.65
6.55
5.65
5.20
4.55
3.55

Figure 16. Isoelectric focusing gel. Lane 1 and 4, protein standards, lane 2 and 3, WDl
and lane 5, WD5-6. WD5-6 migrated 7.9 cm. WDl was used as a control. WDl was
loaded at the cathode (lane2) and at the anode (lane3).
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Figure 17. IEF calibration curve. Linear regression analysis of the standard curve (Figure
16) gave a best fit lin,e with equation 3.3. Equation 3.3 gave a pl of 4.96 for WD5-6. The
pl of WD5-6 predicted from the sequence is 4.87.
y = -0.5784x + 9.4181

3.3

WDP domain one, WD1, that was previously isolated and characterized in our
laboratory, was used as a control. WDl migrated to the same pH both from anode and
cathode. This showed that the gel was run under appropriate conditions. The determined
pl of WD5-6 is consistent with the sequence predicted pl of 4.87.

WD5-6 - Cu binding results

This experiment was done to determine the Cu(l)-WD5-6 binding stochiometry.
Cu(I) solution was added to WD5-6 solution in inert environment and then exchanged in
0.1 M sodium phosphate buffer in Amicon device to wash away unbound Cu. The
resulting Cu(l)WD5-6 complex was then loaded and run on a preequilibrated HRGC
column. A total of 5 mL covering the elution peak of Cu(1)WD5-6 complex from the
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HRGC column was collected and analyzed for Cu and WD5-6 protein content. Protein
concentration was estimated by Biorad protein assay while Cu concentration was
determined by inductively coupled plasma mass spectrometry (ICP-MS). The average
ratio ofWD5-6: Cu was determined to be 0.479 ± 0.0287 (Table 7). This results showed
that WD5-6 binds 2 equivalents of Cu(I) and is consistent with earlier evidence that
showed that the 6 N-terminal metal binding domains ofWDP bind up to 6 equivalents of
Cu (DiDonato et al., 1997).

Trial Cu concentration
(nM)
1
13.25
2
14.99
16.70
3

WD5-6 concentration
(nM)
(µg/mL)
6.83
105.8
118.5
7.38
120.3
7.50

WD5-6:Cu ratio
0.498
0.493
0.446

Table 7. Determination ofWD5-6 and Cu concentrations in the Cu(I)WD5-6 complex by
Biorad protein assay and ICP-MS respectively.
Analytical gel filtration results ofWD5-6 and WD4

This experiment was done to determine the elution parameters ofWD5-6 and
WD4 on HRGC column. The HRGC was to be used to monitor Cu transfer from WD4 to
WD5-6 proteins. WD4 was expressed and purified in a similar manner as WD5-6. The
WD5-6 protein has a MW of 16.05 kDa while WD4 has a MW of7.7 kDa and were
therefore expected to elute at different volumes from HRGC column. Binding of Cu to
Cu binding proteins enhances their extinction coefficients and this increase could be used
to monitor Cu transfer from WD4 to WD5-6. Both proteins were loaded on HRGC
column alone and together to determine their elution parameters before the actual Cu
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transfer experiment. The apo and copper- loaded WD5-6 eluted at about 12.2 mL while
the apo and copper loaded WD4 eluted at about 13.2 mL from HRGC column (Table 8).
All the samples showed a sirrgle distinct UV absorption peak which indicated that they
were homogeneous both in apo and metallated forms. The resolution was, however, poor
between the WD5-6 and WD4 peaks when injected int_o the column simultaneously and
;-

that ruled out the possibility of using this method to perform metal transfer studies
between the two domains. To accomplish metal transfer studies, peak fractions needed to
be collected separately for both WD4 and WD5-6 to be analyzed for Cu and protein
content.

Peakl Elution Peak 2 Elution
volume (mL) volume (mL)
12.214
WD5-6
13.240
WD4
Cu(I)WD5-6 12.212
Cu(I)WD4
13.220
13.260
WD5-6, WD4 12.209
Sample

Table 8. Analysis of WD5-6 and WD4 protein samples by HRGC.

a -Helicity of WD5-6

This experiment was done to determine the a -helicity of WD5-6 protein. The
WD5-6 sample was prepared in 0.01 M sodium phosphate buffer and used for this
experiment. The measurements were taken at a spectropolarimeter at Michigan State
University. The data got were corrected for background noise and used to calculate a helicity of WD5-6.
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The difference in absorption of left and right circularly polarized light yields an
elliptically polarized beam that can be measured by the CD spectropolarimeter, which
converts it into ellipticity by equation 3.4.
3.4
Where 0 is ellipticity in millidegrees, I is the light path length through the cell and AL
and A R are absorbe.ncies for left and right circularly polarized light respectively.
Millidegrees were converted to mean residue molar ellipticity by the equation 3.5.
[0] = 0/l 0Cln

3.5

Where [0] is mean residue molar ellipticity in deg.cm2 ·dmor', C is the protein
concentration in mol/liter and n the number of residues in the protein.
The a-helix presents a minimum signal at 222 nm (Figure 18). The CD signal at
this wavelength was used to calculate a-helicity. The mean residue ellipticity for 100%
helix at 222 nm is obtained by equation 3.6.
[0]222 =

40,000(1-2.5/n)

3.6

Where n is the number of residues in the sequence (which is 149 for WD5-6).
The [0] 222 for WD5-6 equaled -9097.14 while for 100% helicity is equal to -40269.
Percent a-helicity for WD5-6 was therefore calculated to be 23%. This is consistent with
the "ferrodoxine like" fold expected for P-type ATPase metal binding domains.
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Figure 18. CD spectrum ofapo-WD5-6 showing a minimum at 222 nm.

Chemical unfolding ofWD5-6

This experiment was performed to show the unfolding characteristics of
WD5-6. The WD5-6 protein was prepared in 0.01 M sodium phosphate buffer containing
5 mM TCEP.Cl. TCEP.Cl was added to prevent WD5-6 from oxidizing. Guanidium
chloride was used to denature WD5-6 and the unfolding was monitored by emission
spectroscopy at different denaturant concentrations. An excitation spectrum ofWD5-6
showed a maximum at 278 nm (Figure 19), which is typical ofTyr excitation. The
sample was excited at 278 nm and the emission was recorded from 290 nm to 400 nM.
Tyr emission maximum usually occurs at 303 nm. The WD 5-6 protein has 3 Tyr residues
but no Trp.
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WDS-6 Excitation spectrum
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Figure 19. Excitation spectrum of WDS-6. The absorption maximum of about 280 nm is
typical of Tyr excitation spectrum.
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Figure 20. Unfolding plots of WDS-6 at different denaturant concentrations. (a) WDS-6,
(b) 2 M (c) 4 M (d) 6 M (e) 8 M (f) Blank. 2 M to 8 M guanidium chloride was used to
denature WDS-6
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The excitation spectrum of WD5-6 reveals a peak at 278 nm (Figure 19) which is
typical for Tyr absorption. Emission diminished with increasing concentration of
guanidium chloride (Figure 21 ). WD5-6 emission is due to Tyr residues and the
diminishing emission is due to change in the chemical environment due to unfolding.

NMRResults

The NMR experiments were done to elucidate the 3 dimensional structure of
WD5-6, to monitor Cu transfer from Cu(l)WD4 and Cu(l)Atoxl to WD5-6 and to probe
the dynamic of Wd5-6. All the NMR experiments were done at CERM, University of
Florence, Italy.
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Figure 21. 1H 1D NMR spectrum of WD5-6. The amide region (6.5-9.5) is expanded.
The intensity and distribution of peaks seen on this spectrum is a good for NMR
experiments.
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The 1 H ID NMR spectrum ofWD5-6 (Figure 21) showed good peaks and
generally showed that the protein solution was in stable condition suitable for NMR
experiments.

1

H- 15N-HSQC spectrum ofWD5-6
The folded protein or domains of protein displays broad distribution ofNMR

frequency resulting in a good spread-out of cross peak signals in the 1 H- 15N HSQC.
Unfolded proteins show heavy overlap of signals on the 1 H- 15N HSQC spectrum. WD5-6
is well folded according to the 2D 1H - 15N HSQC spectrum (Figure 22). Assignment of
the 1 H- 15N HSQC spectrum is consistent with the WD5-6 protein sequence. The
distribution of signals is crucial for further structural determination and copper binding
experiments.
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Figure 22. The 1 H- 15N HSQC spectrum ofWD5-6.
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Cu(l) - WDS-6 1H- 15 N HSOC NMR titration
The 1H- 15N HSQC NMR spectroscopy was used to monitor Cu(I) binding to
WDS-6. Cu(I) was titrated into labeled WDS-6 protein solution using Hamilton syringe
in Coy chamber under nitrogen atmosphere at 298 K. Upon addition ofCu(I), shifting of
cross peak signals indicate residues that experience a change in their environment
(chemical exchange). The copper binding to WDS-6 produced spectral changes limited to
the two copper binding regions and did not affect its aggregation state as well as the
overall structural properties, in particular without triggering changes ofthe relative
orientation ofthe two subunits (Figure 23). This aspect ofthe 1 H- 15N-HSQC experiment
was utilized during the titration ofCu (I) loaded unlabelled WD4 and Atoxl proteins into
the labeled apo-WDS-6 protein solution.

Cu{l)WD4 - WDS-6 1 H- 15N HSOC NMR titration
The 1H- 15N HSQC NMR spectroscopy was also used to monitor Cu(I) transfer
from unlabeled Cu(l)WD4 and Cu(l)Atoxl to labeled apoWDS-6. The 1 H- 15N spectral
changes upon addition ofincreasing amounts ofthe unlabelled protein partner were
monitored. The metallation ofWDS-6 was monitored through residues Val 19 and 95,
which are next to Cu(I) binding Cys 18 and 94 respectively, and thus showed a large
chemical shift difference between the apo and Cu(I) loaded forms (Figure 24). Another
advantage ofusing these two Val residues was that their NHs cross peaks were not
overlapped in the 1H - 15N HSQC maps ofapo and Cu(I) loaded forms ofWDS-6. This
allowed for easy integration during the titration stages. (Figure 24).
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Figure 23. The weighted chemical shift difference 8avg(HN). {[(8H)2 + (&N/5)2]/2} 1/2
where 8H and 8N are chemical shift difference for l H and 15N, respectively. Chemical
shift differences are not reported for residues 14-17 and 90-93 as their 1 H-l 5N cross
peaks are not observed for apo and Cu(I) forms.
The titration ofCu(l)WD4 into labeled WD5-6 resulted in Val 19 and Val 95
spectral shifts (Figure 24) indicating an interaction that led to Cu(I) transfer from WD4 to
WD5-6, first to WD6 then to WD5 without formation ofan adduct. Titration of
Cu(l)Atox1 with WD4 showed formation ofan adduct that is in fast exchange on the
NMR timescale as confirmed by relaxation measurements. However, the behavior was

dramatically different when Cu(I)Atoxl was titrated into labeled WD5-6. No Cu transfer
occurred from Cu(I)Atoxl to WD5-6 and no stable adduct was formed between the two
proteins even when an excess ofCu(I)Atoxl was added (Cu(I)Atoxl:WD5-6 ratio of
2.5: 1.0). This observation is consistent to the yeast two hybrid data that showed that
Atoxl doesn't interact with WD5-6 (van Dongen et al., 2004).
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Figure 24. Superposition of 1H - 15N HSQC spectra of apoWD5-6 (black) and Cu(l)WD56 (red) showing simultaneous chemical shifts of Val 19 and Val 95.
Solution NMR structure of WD5-6
The secondary structure of WD5-6 derived from solution NMR structure show
that each of the domains bears a ferrodoxine-like structure, pappap (Figure 25). Analysis
of WD5-6 NMR data revealed the following secondary structural elements; p1(41 l ),al(l 8-27), P2(34-38), P3(43-49), a2(56-64), P4(67-70), P5(81-86), a3(94-103),
P6(109-114), P7(119-125), a4(132-140), P8(144-147) (Figure 25). The Cys 15 and
Cys18 which coordinates copper in MBD5 are located at the first loop and first a-helix
regions respectively while Cys 91 and 94 which coordinates copper in MBD6 are located
in the first loop and first a-helix respectively.
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Figure 25. Ribbon diagram representative of the 20 lowest energy conformers of apo
WD5-6. C15, C18, C91 and C94 are the Cu binding residues.
The acquired parameters for NMR experiments performed on WD5-6 {Table 9)
were used to calculate constraints used to elucidate 3D structure of WD5-6. (Figure 25).
1

H, 15N and 13C resonance assignments of human apoWD5-6 at 298 Kin 0.1 M sodium

phosphate buffer, pH 7.2 with 2 mM are available upon request.
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Dimension of acquired data
(nucleus)

Experiments"

t1

[1H-1H]-NOESY
[1H-1H]-TOCSY

1024(1H)
1024(1H)

[1H-1)N]-HSQC

256('�)

[1H-uC]-HSQC
CBCA(CO)NH

-

CBCANH

t3

t2

nb

Spectral width
(ppm)
F1

F3

F2

1

15

15

64

1

2048( H)

15

15

64

2048( H)

1024(1H)

40

7

8

1j

I 024('H)

70

15

8

1J

128( C)

48(')N)

I 024('H)

80

40

15

8

128( 1JC)

48(')N)

1024('H)

80

40

15

16

1J

512( C)

HNCO

96( C)

48(1)N)

1024{'H)

16

40

15

8

HN(CA)CO

96( 1JC)

48{')N)

1024{'H)

16

40

15

16

1024{'H)

88

88

15

8

16

15

1J

1J

uc (H)CCH-TOCSY

272( C)

96( C)

Long-range HNCOc
15N-edited ['H-'H]-NOESY

128{')C)

1024(1H)

256('H)

48{')N)

1024{'H)

15

40

15

16

uC-edited [1H-1H]-NOESY

272{'H)

96( 1JC)

1024{'H)

15

86

15

8

HNHA

I 28{'H)

48{')N)

1024{'H)

15

40

15

16

1J

1024

HNCA

128( C)

48(')N)

1024('H)

45

40

15

8

HN(CO)CA

128( 1JC)

48{')N)

1024{'H)

45

40

15

8

180

20

'JNH ['H-l)N]-HSQC

1)

256( N)

2048{'H)
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"All 3D and 20 spectra were collected at 298 K, processed using the standard Bruker software
(XWINNMR). "Number of acquired scans.c A TROSY version of the long-range HNCO experiment
were acquired at a magnetic field of 800 MHz for hydrogen bond detection.

Table 9. Acquisition parameters for WD5-6 NMR experiments performed on human
apoWD5-6.
Relaxation rate measurements
Relaxation rate measurements were used to probe the dynamics of WD5-6
protein. The overall rotational correlation time (-re ) of WD5-6 was found to be 9.1 ±0.6
ns, which is two times greater than that of WD6 alone (4.5 ns), and is the value expected
for a monomeric protein of 16 kDa.
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Figure 26. 15N relaxation parameters R 1, R2 and 1 H- 15N NOE versus residue number of
apoWLN5-6 collected at 600 MHz.
Relaxation rate measurements also showed that WD5-6 reorients in solution as a
single molecule (i.e. as a dumbbell) rather than as independent beads on a string, with
essentially no relative reorientation of the two individual domains (Figure 26).
Furthermore, the residues linking the two domains of apoWD5-6 did not experience
conformational exchange processes on the ms-µs timescale (Figure 27) indicating the
absence of a multiplicity of relative orientations of the two domains.
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Figure 27. Spectral density function values for the J(wH), l(OON ), and leff(O) terms.
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CHAPTER IV
DISCUSSION

The goals ofthis study were to clone, express, purify and characterize the multi
domain construct ofN-terrninal metal binding domains 5 and 6 ofWilson's disease
protein (WDS-6). The ability ofthis construct to bind copper and to accept copper from
the fourth metal binding domain ofthe same protein was also probed. Elucidation of
solution NMR structure ofWD5-6 was also one ofthe goals ofthis study.
The gene encoding for WD5-6 was cloned into pET24d+ vector successfully and
expressed well in E. coli as host cells. BL21 (DE3) cells were used because oftheir
ability to encode the gene for tRNA ofrare codons allowing for more efficient production
ofeukaryotic proteins that contain rarely used E.coli codons. A yield of12 g/L ofLB
medium was realized for WD5-6. WD4 was also cloned into the same vector and
expressed well in E.coli (BL21) cells. Both were extracted by the freeze thaw method
and purified to homogeneity by two steps including anion exchange chromatography
using a weak anion exchanger, DEAE-Sepharose, and size exclusion gel
chromatography. The purified protein was characterized by various methods including;
high resolution gel filtration chromatography, MALDI-TOF mass spectrometry, laser
light scattering, isoelectric focusing, amino acid hydrolysis and spectroscopic techniques
such as UV-Vis absorption spectroscopy, fluorimetry, CD and NMR spectroscopy.
The purification scheme used for WD5-6 was successful. IEC fractions that had
higher protein concentrations according to the Biorad protein assay (Table 4) also
contained WD5-6 as is evident on SDS-PAGE (Figure 9). This showed the success ofthis
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purification technique. These fractions, however, had some higher and lower molecular
weight proteins which necessitated the use of a different technique that could separate
proteins based on their sizes.-Size exclusion chromatography was used to further purify
the IEC product to homogeneity (Figure 10).
UV absorption spectroscopy and Biorad protein assay are the common
methods for estimation of protein concentration. The UV absorption method, however,
over-estimated the WDS-6 concentration. The molar absorptivity of WDS-6 used
assumed it was fully reduced. The molar absorptivity coefficients of reduced and
oxidized proteins are different. OTT absorbs UV light at around 280 nm so it could not
be used during the measurement and WDS-6 could have been oxidized resulting in this
error.
WDS-6 migrates at a higher mass on HRGC column than the expected MW but

less than the dimer MW. It's safe to conclude that it's monomeric because its apparent
mass is roughly twice the mass of WD6 that was run as a control on the same gel. One
possible reason why HRGC overestimated the MW of WD5-6 is that WDS-6 may not be
as globular (spherical) as the standard proteins used to calibrate the gel. The apparent
molecular mass derived from HRGC is a function of molecular mass and shape therefore
the difference in size of the proteins could make them run differently on gels. WDS-6 and
WD4 couldn't be completely separated by use of high-resolution gel chromatography.
Consequently, metal transfer studies between them cannot be accomplished by this
method. These two proteins elute at different ionic strengths in IEC column. WD4 elutes
at much higher ionic strength compared to WDS-6 and this is a good basis for carrying
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out metal transfer experiment that should be pursued to supplement the NMR titration
results.
WDS-6 has two meta�binding motifs, one in each domain. The discovery that this
WDS-6 binds two equivalents of copper is consistent with the previous results which
show that the 6 N-terminal MBDs ofWDP is capable of binding up to 6 equivalents of
Cu(I) (DiDonato et ·al., 1997).
The laser light scattering (LLS) experiment showed two peaks (Figure 14) which
are clearly for WDS-6 in the monomeric and the dimeric state. WDS-6 is rich in cystein
and is more likely to oxidize by forming inter-domain disulfide bonds and that explains
the appearance of the dimer forms. Unlike the conventional SEC method, the molecular
mass from LLS is independent of the elution volume. It therefore, can be used for sticky
proteins which elute unusually late as a result of interaction with the column matrix.
Cu (I) did not cause aggregation because the apparent running mass for apo- and
Cu (I) WDS-6 and are nearly the same (Table 7). Because WDS-6 is rich in Cys, it has
the potential of forming intermolecular S-Cu-S links during titration of Cu (I) into the apo
protein. The other likely causes of aggregation for cystein rich proteins like WDS-6 are
intermolecular S-S links from oxidation of Cys residues by 02. Aggregation status is
critical for both structural and copper binding studies. WDS-6 was confirmed to be
monomeric in reduced form by HRGC (Figure 13).
Preliminary data presented on chemical unfolding of WDS-6 forms a good basis
for more unfolding and refolding experiments. Emission should be tested at more
intermediary concentrations of guanidium chloride to enable calculation of unfolding
energy ofWDS-6. The results showed no peak shift in emission spectrum (Figure 19)
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with increase in guanidium chloride concentration, but the decrease in fluorescence is not
uniform with increase ofdenaturant concentration.
The use ofheteronuclei, 15N and 13 C, allows some new features in NMR which
facilitate the structure determination, especially oflarger proteins (more than 100 amino
acids). However their natural abundance and gyromagnetic ratio are markedly lower than
that ofthe proton (Table 9). Two strategies used to increase the low sensitivity ofthese
nuclei are isotopic enrichment ofthese nuclei in proteins and enhancement ofthe signal
to noise ratio by the use ofinverse NMR experiment in which the magnetization is
transferred from protons to the heteronucleus (HSQC). Other reasons for using 15N and
13 C

to label proteins are because they are not radioactive and therefore harmless and they

have a spin of ½ and therefore can only have two quantum energy levels.

Isotope Spin I Natural
abundance (%)
99.98
'H
½
1
LH
0.016
98.9
ILC
0
1.108
uc
½
1
14N
99.63
0.37
"N
½
loo
98.9
0
5/2
"O
0.037
Jl
p
100
½

Gyromagnetic Relative
ratio(y)
sensitivity
26.7519
1.00
4.1066
9.65*10-0

Absolute
sensitivity
1.00
1.45*10°

6.7283
1.9338
-2.712

l .76*10-4
1.01*10-j
1.04*10-j

--

--

--

--

-3.6279
10.841

1.59*10-L
1.01*10-j
1.04*10-j

2.9)*)0-L
6.63*10-L

--

--

1.08*10-)
6.63*10-L

Table 10. Most common isotopes encountered in biology and their relative abundance.
Relative sensitivity is given at constant magnetic field and equal number ofnuclei.
Absolute sensitivity is the product ofrelative sensitivity multiplied by natural abundance.
The ID NMR spectrum peaks for WDS-6 protein (Figure 20) showed good signal
to noise ratio, which is indicative ofa good condition for the NMR experiments. The
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numerous chemical shift peaks seen for amide protons between 6.5- 9.5, for the alpha
protons 3-5 and for aliphatic protons 0.5 to 3 is a clear indication that the sample was in a
stable condition, optimal for NMR experiments. The 2D HSQC spectrum of WD5-6
(Figure 21) was consistent with the WD5-6 amino acid sequence and this is a key step in
protein NMR. The 2D spectrum with 1 H and

15

N dimensions was used to determine

whether the protein.was well folded and is in optimal NMR experimental conditions,
protein oligomeric status and quality control. WD5-6 is well folded because its HSQC
spectrum of WD5-6 showed good dispersion of resonance. The sharp dispersed signals
on HSQC spectrum is also a good indicator of optimal NMR experiment conditions and
of the monomeric nature of WD5-6. Monomeric proteins show sharp signals on HSQC
spectrum. HSQC is a good tool to probe whether the protein sample changes over a
period of time and that for WD5-6 showed no peak shift over a period of six months.
The apoWD5-6 protein structure was shown to be organized in two subunits with
ferrodoxin-like fold connected by a short linker (Figure 25). The fold of each subunit and
their Cu binding sites structural properties are same to that found in the yeast homologue
(Banci et al., 2001). The solution structure, hydrodynamic behavior, and relaxation
parameters of WD5-6 reveal that this multidomain construct behaves as a unit in solution,
with the metal binding domains facing away from each other, disallowing intramolecular
Cu transfer between WD5 and WD6.
Copper binding produced spectral changes limited to the two Cu binding regions
and did not affect its aggregation state as well as the overall structural properties. The
observation that WD5-6 is able to accept Cu from another metal binding domain (WD4)
and not from Atoxl , as shown by NMR titration experiment, is consistent with earlier
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evidence from yeast hybrid experiment which showed no interaction between the Atoxl
and WD5-6 but showed a strong interaction between Atoxl and WD4 ( van Dongen et al.,
2004). No stable adduct was formed between WD5-6 and Cu(l)Atox I but an adduct
formed when WD4 was titrated with Cu(l)Atoxl. These observations suggest that WD4
acquire cu from Atoxl and channel it through WD5-6 to the vesicular Cu pump.
The mechanism of adduct formation and Cu transfer between WD4 and WD5-6
may involve surface potential complimentarity between the two proteins. Atoxl has a
similar positive surface region as Atxl in the portion known to be involved in the
interaction with Ccc2a, while WD5, 6 and Ccc2a have negative surface regions
complimentary to those of Atoxl and Atxl. Atxl is Cu chaperone that deliver Cu to
Ccc2a protein in yeast (Rosenzweig et al., 1999).
The other domain shown to interact with human copper chaperone, Atox1, is
domain 2 (van Dongen et al., 2004; Walker et al., 2004) but it was shown that copper
doesn't flow from this domain to the other domains (Walker et al., 2004). These results
are not conclusive on the functional significance of copper binding to WD2. One
suggestion was that copper binding to WD2 may trigger conformational changes in WDP
leading to copper binding to the other domains. This would be consistent with the
observation that a multi-domain construct of WD 1-4 shows a stronger interaction with
Atox1 than any one single domain.
The observation that Atoxl did not interact with WD5-6 raises the question as to·
what the effects of the 2 disease causing mutations in WD5-6 might be. This finding fails
to support the earlier belief that the 2 mutations in the highly conserved residues interfere
with interaction between the domains and the Atoxl and therefore Cu transfer between
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N-WDP and Atox I. We have initiated studies aimed at characterizing the 2 mutations in
WD5-6 with regards to Cu transfer between mutant WD5-6 and other WOP MBDs. We
are also interested in understanding how the 2 disease causing mutations in the WD5-6
interfere with its function.

Conclusion

We have cloned and isolated WD5-6. We have shown that it binds 2 equivalents of
copper, has a pl of 4.96 and a-helicity of 23%. We have shown by NMR spectroscopy
that WD5-6 has a pappap fold in each of the 2 domains and behaves as a unit in solution.
We also showed by NMR titration that WD5-6 interacts with WD4 but not with Atoxl.
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